syndrome	score	normalized_score
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	100.0
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.20831565900000001	20.8315659
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.205896724	20.5896724
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	20.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2	20.0
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	20.0
TARP SYNDROME	0.15239757899999998	15.239757899999997
OROFACIODIGITAL SYNDROME I; OFD1	0.14606065	14.606065
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.14606065	14.606065
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.14606065	14.606065
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.145796179	14.5796179
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04448735499999999	4.448735499999999
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.043266529	4.3266529
OKAMOTO SYNDROME	0.04286007899999999	4.286007899999999
KABUKI SYNDROME 1	0.038380848999999995	3.8380848999999992
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.036990553999999995	3.6990553999999993
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.036491745	3.6491745
KOOLEN-DE VRIES SYNDROME; KDVS	0.035327879	3.5327878999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.034705579	3.4705579
2P15P16.1 MICRODELETION SYNDROME	0.034483329	3.4483329
DISTAL MONOSOMY 10Q	0.033891664	3.3891664
RING CHROMOSOME 7 SYNDROME	0.03290435	3.290435
LATHOSTEROLOSIS	0.032089704	3.2089703999999997
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.03203505	3.2035050000000003
JOHANSON-BLIZZARD SYNDROME; JBS	0.031099300000000003	3.1099300000000003
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.030734125	3.0734125
AYMÉ-GRIPP SYNDROME	0.030435899	3.0435898999999997
LATERAL MENINGOCELE SYNDROME	0.030435899	3.0435898999999997
DISTAL MONOSOMY 17Q	0.030142460000000003	3.0142460000000004
BECKWITH-WIEDEMANN SYNDROME	0.030142460000000003	3.0142460000000004
WITTEVEEN-KOLK SYNDROME	0.030099729	3.0099728999999997
CARDIOFACIOCUTANEOUS SYNDROME	0.029930789	2.9930789
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.0297391	2.97391
ROIFMAN SYNDROME; RFMN	0.028935764	2.8935763999999997
SILVER-RUSSELL SYNDROME	0.027675715	2.7675715
BOHRING-OPITZ SYNDROME	0.027635824	2.7635823999999998
HEART AND BRAIN MALFORMATION SYNDROME	0.027635824	2.7635823999999998
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.027181579000000004	2.7181579000000005
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.027039600000000004	2.7039600000000004
CONGENITAL MYASTHENIC SYNDROME	0.027039600000000004	2.7039600000000004
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.026878598999999996	2.6878598999999994
9Q33.3Q34.11 MICRODELETION SYNDROME	0.02670913	2.670913
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.026636025000000004	2.6636025000000005
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.026636025000000004	2.6636025000000005
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.026636025000000004	2.6636025000000005
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.026636025000000004	2.6636025000000005
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.026636025000000004	2.6636025000000005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.026636025000000004	2.6636025000000005
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.026636025000000004	2.6636025000000005
TRISOMY 17P	0.026483329	2.6483328999999998
2Q31.1 MICRODELETION SYNDROME	0.026483329	2.6483328999999998
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.026251353999999998	2.6251353999999996
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.026186554000000004	2.6186554000000006
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.026186554000000004	2.6186554000000006
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.026186554000000004	2.6186554000000006
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.026186554000000004	2.6186554000000006
DYSTONIA 28, CHILDHOOD-ONSET	0.026186554000000004	2.6186554000000006
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.026186554000000004	2.6186554000000006
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.025705799999999997	2.5705799999999996
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.025641000000000004	2.5641000000000003
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.025641000000000004	2.5641000000000003
MIYOSHI MYOPATHY	0.025641000000000004	2.5641000000000003
BECKER MUSCULAR DYSTROPHY	0.025641000000000004	2.5641000000000003
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.025641000000000004	2.5641000000000003
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.025641000000000004	2.5641000000000003
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.025641000000000004	2.5641000000000003
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.025641000000000004	2.5641000000000003
CAP MYOPATHY	0.025641000000000004	2.5641000000000003
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.025641000000000004	2.5641000000000003
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.025641000000000004	2.5641000000000003
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.025641000000000004	2.5641000000000003
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.025641000000000004	2.5641000000000003
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.025641000000000004	2.5641000000000003
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.025641000000000004	2.5641000000000003
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.025641000000000004	2.5641000000000003
MYOPATHIC EHLERS-DANLOS SYNDROME	0.025641000000000004	2.5641000000000003
OPITZ G/BBB SYNDROME	0.025488304	2.5488304
AU-KLINE SYNDROME; AUKS	0.025098858999999998	2.5098858999999996
14Q12 MICRODELETION SYNDROME	0.024539175	2.4539175
MECKEL SYNDROME	0.024393400000000003	2.43934
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.024105134	2.4105134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.024089704	2.4089704
20Q11.2 MICRODUPLICATION SYNDROME	0.024089704	2.4089704
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.024089704	2.4089704
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.024078523999999997	2.4078524
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.023939419999999996	2.3939419999999996
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.023939419999999996	2.3939419999999996
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.023939419999999996	2.3939419999999996
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.023683254	2.3683254000000002
BOHRING-OPITZ SYNDROME	0.023683254	2.3683254000000002
ADENYLOSUCCINASE DEFICIENCY	0.023683254	2.3683254000000002
SWEENEY-COX SYNDROME; SWCOS	0.023683254	2.3683254000000002
MARDEN-WALKER SYNDROME	0.023285149	2.3285149
1Q44 MICRODELETION SYNDROME	0.023279679	2.3279679
6Q TERMINAL DELETION SYNDROME	0.023279679	2.3279679
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.023279679	2.3279679
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.023251454	2.3251454000000003
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0231377	2.31377
MEIER-GORLIN SYNDROME 5; MGORS5	0.0231377	2.31377
OROFACIODIGITAL SYNDROME XVII	0.0231377	2.31377
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.022926028999999997	2.2926029
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.022926028999999997	2.2926029
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.022734125	2.2734125
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.022734125	2.2734125
NIJMEGEN BREAKAGE SYNDROME	0.0227059	2.2705900000000003
CHROMOSOME 5Q12 DELETION SYNDROME	0.022679923999999997	2.2679924
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.022476004999999997	2.2476005
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.022407674	2.2407673999999997
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.022407674	2.2407673999999997
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.022284654	2.2284654
TRANSIENT NEONATAL DIABETES MELLITUS	0.022284654	2.2284654
PERMANENT NEONATAL DIABETES MELLITUS	0.022284654	2.2284654
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.022284654	2.2284654
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.022134369999999997	2.213437
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.022134369999999997	2.213437
THAKKER-DONNAI SYNDROME	0.022134369999999997	2.213437
ROBERTS SYNDROME; RBS	0.02186212	2.186212
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.02175323	2.1753229999999997
BECKWITH-WIEDEMANN SYNDROME	0.0217391	2.1739100000000002
COFS SYNDROME	0.0217391	2.1739100000000002
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0217391	2.1739100000000002
DEND SYNDROME	0.0217391	2.1739100000000002
SUMMITT SYNDROME	0.0217391	2.1739100000000002
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.021112779	2.1112779
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.020981874999999997	2.0981875
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.020744999	2.0744999
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.020532403999999997	2.0532403999999995
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.020532403999999997	2.0532403999999995
CORNELIA DE LANGE SYNDROME	0.02045156	2.045156
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.020125953999999998	2.0125954
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.020125953999999998	2.0125954
BARAITSER-WINTER SYNDROME 1; BRWS1	0.020125953999999998	2.0125954
KBG SYNDROME	0.019722378999999998	1.9722378999999999
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.019722378999999998	1.9722378999999999
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.019653495	1.9653495
ADNP SYNDROME	0.019580399999999998	1.9580399999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.019580399999999998	1.9580399999999998
JOUBERT SYNDROME	0.019332579000000003	1.9332579000000003
19P13.3 MICRODUPLICATION SYNDROME	0.019273204	1.9273204
9Q21.13 MICRODELETION SYNDROME	0.019176824999999998	1.9176824999999997
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01913101	1.913101
PETERS-PLUS SYNDROME; PTRPLS	0.018939949	1.8939949
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.018727353999999998	1.8727353999999998
X SMALL RINGS	0.018727353999999998	1.8727353999999998
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.018727353999999998	1.8727353999999998
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.018727353999999998	1.8727353999999998
KBG SYNDROME	0.018727353999999998	1.8727353999999998
MENTAL RETARDATION, X-LINKED 9	0.018727353999999998	1.8727353999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018727353999999998	1.8727353999999998
8Q12 MICRODUPLICATION SYNDROME	0.018727353999999998	1.8727353999999998
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.018727353999999998	1.8727353999999998
RING CHROMOSOME 13 SYNDROME	0.01865847	1.865847
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.018657654000000003	1.8657654000000004
NOONAN SYNDROME 6; NS6	0.018455104	1.8455104
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.018455104	1.8455104
19P13.13 MICRODELETION SYNDROME	0.018455104	1.8455104
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.018455104	1.8455104
TURCOT SYNDROME WITH POLYPOSIS	0.018277329999999998	1.8277329999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.018254294	1.8254294
AGNATHIA-OTOCEPHALY COMPLEX	0.01819845	1.8198450000000002
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.018181799999999998	1.81818
FAMILIAL INTESTINAL MALROTATION	0.018181799999999998	1.81818
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.018181799999999998	1.81818
CRANIOSYNOSTOSIS, PHILADELPHIA TYPE	0.018181799999999998	1.81818
BARAITSER-WINTER SYNDROME 2; BRWS2	0.018181799999999998	1.81818
ROIFMAN SYNDROME	0.018181799999999998	1.81818
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.018181799999999998	1.81818
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.018181799999999998	1.81818
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.017970234	1.7970234
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01790955	1.790955
HYPOGLOSSIA WITH SITUS INVERSUS	0.017792000000000002	1.7792000000000003
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.017645078999999998	1.7645078999999997
PIERPONT SYNDROME	0.017541349	1.7541349000000002
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.017505975	1.7505975
MOWAT-WILSON SYNDROME; MOWS	0.01742468	1.7424680000000001
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.017410514	1.7410514
RENPENNING SYNDROME 1; RENS1	0.017388425000000002	1.7388425000000003
MARFANOID HABITUS WITH SITUS INVERSUS	0.017388425000000002	1.7388425000000003
PRIMARY CILIARY DYSKINESIA	0.017388425000000002	1.7388425000000003
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.01732596	1.732596
ANGELMAN SYNDROME	0.017160209000000003	1.7160209000000002
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.017160209000000003	1.7160209000000002
9P13 MICRODELETION SYNDROME	0.017099524999999997	1.7099524999999998
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.017056504	1.7056504000000001
DEXTROCARDIA	0.016938954000000003	1.6938954000000002
BARDET-BIEDL SYNDROME 8; BBS8	0.016938954000000003	1.6938954000000002
BARDET-BIEDL SYNDROME 17; BBS17	0.016938954000000003	1.6938954000000002
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.016554605	1.6554605
SMITH-KINGSMORE SYNDROME; SKS	0.01651095	1.651095
LEGIUS SYNDROME	0.01651095	1.651095
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.016393400000000002	1.6393400000000002
CONGENITAL PSEUDOARTHROSIS OF THE CLAVICLE	0.016393400000000002	1.6393400000000002
ELLIS VAN CREVELD SYNDROME	0.016393400000000002	1.6393400000000002
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.016393400000000002	1.6393400000000002
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 16; CILD16	0.016393400000000002	1.6393400000000002
MEACHAM SYNDROME	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 28; CILD28	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 26; CILD26	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 25; CILD25	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 23; CILD23	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 22; CILD22	0.016393400000000002	1.6393400000000002
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.016393400000000002	1.6393400000000002
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 19; CILD19	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	0.016393400000000002	1.6393400000000002
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 40; CILD40	0.016393400000000002	1.6393400000000002
PAGOD SYNDROME	0.016393400000000002	1.6393400000000002
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.016393400000000002	1.6393400000000002
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.016393400000000002	1.6393400000000002
HETEROTAXY, VISCERAL, 2, AUTOSOMAL	0.016393400000000002	1.6393400000000002
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.016393400000000002	1.6393400000000002
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.016393400000000002	1.6393400000000002
ISOLATED CLEFT LIP	0.016393400000000002	1.6393400000000002
POLYCYSTIC KIDNEY DISEASE 2	0.016393400000000002	1.6393400000000002
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.016393400000000002	1.6393400000000002
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.016165184000000003	1.6165184000000004
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.016165184000000003	1.6165184000000004
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.016165184000000003	1.6165184000000004
COSTELLO SYNDROME; CSTLO	0.016105134	1.6105134
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0161045	1.6104500000000002
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.015797404	1.5797404000000002
PITT-HOPKINS SYNDROME	0.015619630000000002	1.5619630000000002
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.015619630000000002	1.5619630000000002
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.01555958	1.555958
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.015393829000000003	1.5393829000000003
JACOBSEN SYNDROME	0.015320419000000002	1.5320419000000003
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.015251454	1.5251454
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.015251454	1.5251454
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.015251454	1.5251454
SILVER-RUSSELL SYNDROME; SRS	0.015251454	1.5251454
2Q23.1 MICRODUPLICATION SYNDROME	0.015251454	1.5251454
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.015251454	1.5251454
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.015251454	1.5251454
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.015251454	1.5251454
SYNDROMIC DIARRHEA	0.015251454	1.5251454
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.015251454	1.5251454
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.015251454	1.5251454
COFFIN-LOWRY SYNDROME; CLS	0.014848275000000003	1.4848275000000002
COFFIN-LOWRY SYNDROME	0.014848275000000003	1.4848275000000002
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.014848275000000003	1.4848275000000002
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.0147059	1.4705899999999998
RUSSELL-SILVER SYNDROME, X-LINKED	0.0147059	1.4705899999999998
FANCONI ANEMIA	0.0147059	1.4705899999999998
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.0147059	1.4705899999999998
NEUROFIBROMATOSIS, TYPE II	0.0147059	1.4705899999999998
7Q11.23 MICRODUPLICATION SYNDROME	0.0147059	1.4705899999999998
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.0147059	1.4705899999999998
TUBEROUS SCLEROSIS 2; TSC2	0.0147059	1.4705899999999998
NF1-MICRODELETION SYNDROME	0.0147059	1.4705899999999998
GASTROCUTANEOUS SYNDROME	0.0147059	1.4705899999999998
CENTRAL PRECOCIOUS PUBERTY	0.0147059	1.4705899999999998
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.0147059	1.4705899999999998
BLOOM SYNDROME	0.0147059	1.4705899999999998
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.0147059	1.4705899999999998
TUBEROUS SCLEROSIS-1	0.0147059	1.4705899999999998
CARNEY COMPLEX	0.0147059	1.4705899999999998
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0147059	1.4705899999999998
PHEOCHROMOCYTOMA	0.0147059	1.4705899999999998
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0147059	1.4705899999999998
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.0147059	1.4705899999999998
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.0147059	1.4705899999999998
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.0147059	1.4705899999999998
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.014441825000000002	1.4441825000000001
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.014398804000000003	1.4398804000000003
HELSMOORTEL-VAN DER AA SYNDROME	0.014398804000000003	1.4398804000000003
FG SYNDROME TYPE 1	0.014325394000000002	1.4325394000000002
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.014300084000000001	1.4300084000000002
TYSHCHENKO SYNDROME	0.014300084000000001	1.4300084000000002
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.014275195000000001	1.4275195
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.013992354000000002	1.3992354000000002
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.013992354000000002	1.3992354000000002
DOORS SYNDROME	0.013992354000000002	1.3992354000000002
TURNPENNY-FRY SYNDROME; TPFS	0.013992354000000002	1.3992354000000002
CHROMOSOME 19P13.13 DELETION SYNDROME	0.013922034000000002	1.3922034
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.013918944	1.3918944
EMANUEL SYNDROME	0.013918944	1.3918944
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.013896724	1.3896723999999998
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013896724	1.3896723999999998
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.013853250000000003	1.3853250000000004
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.013853250000000003	1.3853250000000004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.013825724000000001	1.3825724000000001
SMITH-FINEMAN-MYERS SYNDROME	0.01375762	1.375762
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.013588779000000002	1.3588779000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.013588779000000002	1.3588779000000002
ALPHA-MANNOSIDOSIS	0.013588779000000002	1.3588779000000002
SSR4-CDG	0.013588779000000002	1.3588779000000002
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.013588779000000002	1.3588779000000002
CORNELIA DE LANGE SYNDROME 1	0.013446800000000002	1.34468
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.013446800000000002	1.34468
TEMPLE SYNDROME	0.013350955000000001	1.3350955000000002
RAYNAUD-CLAES SYNDROME; MRXSRC	0.013054369000000001	1.3054369000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.013043225000000002	1.3043225000000003
KABUKI SYNDROME	0.013043225000000002	1.3043225000000003
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.013043225000000002	1.3043225000000003
MUCOPOLYSACCHARIDOSIS TYPE 1	0.013043225000000002	1.3043225000000003
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.013043225000000002	1.3043225000000003
17Q23.1Q23.2 MICRODELETION SYNDROME	0.013043225000000002	1.3043225000000003
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.013043225000000002	1.3043225000000003
MORQUIO SYNDROME A	0.013043225000000002	1.3043225000000003
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.012969815	1.2969815
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.012647919	1.2647919
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.012647919	1.2647919
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.012593754000000002	1.2593754000000001
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.012593754000000002	1.2593754000000001
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.012593754000000002	1.2593754000000001
MEHMO SYNDROME; MEHMO	0.012593754000000002	1.2593754000000001
PHELAN-MCDERMID SYNDROME	0.012593754000000002	1.2593754000000001
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.012593754000000002	1.2593754000000001
PETERS PLUS SYNDROME	0.012593754000000002	1.2593754000000001
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.012593754000000002	1.2593754000000001
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.012520344000000001	1.2520344
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.012520344000000001	1.2520344
KAGAMI-OGATA SYNDROME	0.012520344000000001	1.2520344
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.012355930000000001	1.2355930000000002
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.012355930000000001	1.2355930000000002
CHROMOSOME 1P36 DELETION SYNDROME	0.012268229	1.2268229
611961 STEVENSON-CAREY SYNDROME	0.012268229	1.2268229
SECKEL SYNDROME 1; SCKL1	0.012198674999999999	1.2198674999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.012059344000000001	1.2059344
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.012059344000000001	1.2059344
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.012059344000000001	1.2059344
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.012048200000000002	1.2048200000000002
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.012048200000000002	1.2048200000000002
CRANIOECTODERMAL DYSPLASIA 1	0.012048200000000002	1.2048200000000002
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.012048200000000002	1.2048200000000002
OHDO SYNDROME	0.012048200000000002	1.2048200000000002
SOMATOMAMMOTROPINOMA	0.012048200000000002	1.2048200000000002
ACROMEGALY	0.012048200000000002	1.2048200000000002
CRANIOECTODERMAL DYSPLASIA 3	0.012048200000000002	1.2048200000000002
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.012048200000000002	1.2048200000000002
ANGELMAN SYNDROME	0.012048200000000002	1.2048200000000002
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.012048200000000002	1.2048200000000002
AMELOGENESIS IMPERFECTA, TYPE IJ	0.012048200000000002	1.2048200000000002
ZUNICH NEUROECTODERMAL SYNDROME	0.012048200000000002	1.2048200000000002
MUCOPOLYSACCHARIDOSIS, TYPE II	0.012048200000000002	1.2048200000000002
CEREBROOCULONASAL SYNDROME	0.012048200000000002	1.2048200000000002
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.012048200000000002	1.2048200000000002
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.012048200000000002	1.2048200000000002
EEM SYNDROME	0.012048200000000002	1.2048200000000002
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.012048200000000002	1.2048200000000002
CARPENTER-WAZIRI SYNDROME	0.012048200000000002	1.2048200000000002
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.012048200000000002	1.2048200000000002
TRICHODENTOOSSEOUS SYNDROME	0.012048200000000002	1.2048200000000002
TRICHO-DENTO-OSSEOUS SYNDROME	0.012048200000000002	1.2048200000000002
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	1.1974790000000002
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.01195257	1.195257
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011749204	1.1749204
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.011722675	1.1722675
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.011652894	1.1652894
GMS SYNDROME	0.011607010000000001	1.160701
COFFIN-SIRIS SYNDROME 7; CSS7	0.011273204	1.1273204000000001
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.011249319	1.1249319
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.01110734	1.110734
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.010939179	1.0939179
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.010869629	1.0869629
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.01072765	1.072765
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.010703765	1.0703765
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.010703765	1.0703765
PITT-HOPKINS-LIKE SYNDROME	0.010703765	1.0703765
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010703765	1.0703765
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.010463179	1.0463179
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010463179	1.0463179
NEU-LAXOVA SYNDROME 2; NLS2	0.010393625	1.0393625
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.010350604000000001	1.0350604
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010347514	1.0347514
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.010254294	1.0254294000000002
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.010254294	1.0254294000000002
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.010254294	1.0254294000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.010254294	1.0254294000000002
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.010254294	1.0254294000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.010254294	1.0254294000000002
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.010254294	1.0254294000000002
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.010254294	1.0254294000000002
MYOCLONIC-ASTASTIC EPILEPSY	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.010254294	1.0254294000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.010254294	1.0254294000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.010254294	1.0254294000000002
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.010254294	1.0254294000000002
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.010254294	1.0254294000000002
EARLY MYOCLONIC ENCEPHALOPATHY	0.010254294	1.0254294000000002
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.010254294	1.0254294000000002
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.010254294	1.0254294000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.010254294	1.0254294000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.010254294	1.0254294000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.010254294	1.0254294000000002
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.010208410000000001	1.020841
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.010208410000000001	1.020841
DIAMOND-BLACKFAN ANEMIA 1	0.010208410000000001	1.020841
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.010208410000000001	1.020841
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.009944154	0.9944154000000001
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.009944154	0.9944154000000001
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.009944154	0.9944154000000001
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.009944154	0.9944154000000001
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.009944154	0.9944154000000001
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009944154	0.9944154000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009943939	0.9943939
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.009943939	0.9943939
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.009874604	0.9874604
ACROCRANIOFACIAL DYSOSTOSIS	0.009805050000000001	0.9805050000000001
DISTAL TRISOMY 15Q	0.009805050000000001	0.9805050000000001
LATHOSTEROLOSIS	0.009805050000000001	0.9805050000000001
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.009805050000000001	0.9805050000000001
SECKEL SYNDROME 5; SCKL5	0.009805050000000001	0.9805050000000001
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.009805050000000001	0.9805050000000001
YUNIS-VARON SYNDROME	0.00980196	0.9801960000000001
INTERMEDIATE NEMALINE MYOPATHY	0.00980196	0.9801960000000001
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00980196	0.9801960000000001
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00980196	0.9801960000000001
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00980196	0.9801960000000001
GAUCHER DISEASE, PERINATAL LETHAL	0.00980196	0.9801960000000001
KNIEST-LIKE DYSPLASIA, LETHAL	0.00980196	0.9801960000000001
RESTRICTIVE DERMOPATHY, LETHAL	0.00980196	0.9801960000000001
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00970874	0.970874
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00970874	0.970874
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00970874	0.970874
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.00970874	0.970874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.00970874	0.970874
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.009540579	0.9540579
FANCONI ANEMIA	0.009540579	0.9540579
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.009468154	0.9468154
WHITE-SUTTON SYNDROME; WHSUS	0.009468154	0.9468154
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.009468154	0.9468154
NON-DISTAL MONOSOMY 20Q	0.0093986	0.93986
DUBOWITZ SYNDROME	0.0093986	0.93986
MECKEL SYNDROME, TYPE 1; MKS1	0.0093986	0.93986
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0093986	0.93986
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0093986	0.93986
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0093986	0.93986
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0093986	0.93986
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.0093986	0.93986
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0093986	0.93986
MECKEL SYNDROME 12; MKS12	0.0093986	0.93986
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009398385	0.9398385
TEMPLE SYNDROME	0.009398385	0.9398385
MICROFORM HOLOPROSENCEPHALY	0.009398385	0.9398385
CLASSICAL EHLERS-DANLOS SYNDROME	0.009398385	0.9398385
PELIZAEUS-MERZBACHER DISEASE	0.009398385	0.9398385
NEU-LAXOVA SYNDROME	0.008995025	0.8995025
INTELLECTUAL DISABILITY, WOLFF TYPE	0.008995025	0.8995025
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.008995025	0.8995025
DUBOWITZ SYNDROME	0.008995025	0.8995025
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.008995025	0.8995025
CLEIDOCRANIAL DYSPLASIA	0.008995025	0.8995025
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.008995025	0.8995025
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.008995025	0.8995025
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.008995025	0.8995025
GALLOWAY-MOWAT SYNDROME	0.008948914	0.8948914
PEDIATRIC-ONSET GRAVES DISEASE	0.008948914	0.8948914
CINCA SYNDROME	0.008948914	0.8948914
ROBERTS SYNDROME	0.008948914	0.8948914
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.008948914	0.8948914
KAGAMI-OGATA SYNDROME	0.008948914	0.8948914
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.8948914
VASCULAR EHLERS-DANLOS SYNDROME	0.008948914	0.8948914
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.8948914
INFANTILE SIALIC ACID STORAGE DISEASE	0.008948914	0.8948914
CONGENITAL TOXOPLASMOSIS	0.008948914	0.8948914
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	0.8948914
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008948914	0.8948914
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008948914	0.8948914
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008948914	0.8948914
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008948914	0.8948914
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.8948914
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.8948914
KAPUR-TORIELLO SYNDROME	0.0089226	0.8922599999999999
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0089226	0.8922599999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.008696799	0.8696799
COFFIN-SIRIS SYNDROME 1; CSS1	0.008696799	0.8696799
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.008696799	0.8696799
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.008696799	0.8696799
LAMB-SHAFFER SYNDROME	0.008696799	0.8696799
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.008696799	0.8696799
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.008696799	0.8696799
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.008545554	0.8545554000000001
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.008545554	0.8545554000000001
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.008545554	0.8545554000000001
SAY-BARBER-MILLER SYNDROME	0.008545554	0.8545554000000001
PEHO-LIKE SYNDROME; PEHOL	0.008545554	0.8545554000000001
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.008545554	0.8545554000000001
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.008545554	0.8545554000000001
WARSAW BREAKAGE SYNDROME; WABS	0.008545554	0.8545554000000001
MATERNAL PHENYLKETONURIA	0.008545554	0.8545554000000001
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.008545554	0.8545554000000001
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.008545554	0.8545554000000001
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008545554	0.8545554000000001
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.008545554	0.8545554000000001
COG4-CDG	0.008545554	0.8545554000000001
LISSENCEPHALY 2; LIS2	0.008545554	0.8545554000000001
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.008545554	0.8545554000000001
KEUTEL SYNDROME	0.008545554	0.8545554000000001
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.008545554	0.8545554000000001
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.008545554	0.8545554000000001
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.008545554	0.8545554000000001
OROFACIODIGITAL SYNDROME TYPE 14	0.008545554	0.8545554000000001
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.8403360000000001
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.8403360000000001
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.8403360000000001
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.8403360000000001
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.8403360000000001
SCHISIS ASSOCIATION	0.00840336	0.8403360000000001
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.8403360000000001
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8403360000000001
RETINOPATHY OF PREMATURITY	0.00840336	0.8403360000000001
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.8403360000000001
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.8403360000000001
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8403360000000001
FATCO SYNDROME	0.00840336	0.8403360000000001
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8403360000000001
CONGENITAL ANALBUMINEMIA	0.00840336	0.8403360000000001
NEMALINE MYOPATHY 10	0.00840336	0.8403360000000001
HEC SYNDROME	0.00840336	0.8403360000000001
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.8403360000000001
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.8403360000000001
EBSTEIN MALFORMATION	0.00840336	0.8403360000000001
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.8403360000000001
VACTERL/VATER ASSOCIATION	0.00840336	0.8403360000000001
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.8403360000000001
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.8403360000000001
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.8403360000000001
PEMPHIGOID GESTATIONIS	0.00840336	0.8403360000000001
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.8403360000000001
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8403360000000001
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.8403360000000001
OMPHALOCELE	0.00840336	0.8403360000000001
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.8403360000000001
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.8403360000000001
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.8403360000000001
RENAL TUBULAR DYSGENESIS	0.00840336	0.8403360000000001
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.8403360000000001
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.8403360000000001
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.8403360000000001
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.8403360000000001
HYDROLETHALUS	0.00840336	0.8403360000000001
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.8403360000000001
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.8403360000000001
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.8403360000000001
ZELLWEGER SYNDROME	0.00840336	0.8403360000000001
ADAMS-OLIVER SYNDROME	0.00840336	0.8403360000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.8403360000000001
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.8403360000000001
22Q11.2 DELETION SYNDROME	0.008315659000000001	0.8315659000000001
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.008315659	0.8315659
SHPRINTZEN-GOLDBERG SYNDROME	0.008151245	0.8151244999999999
FONTAINE PROGEROID SYNDROME; FPS	0.008151245	0.8151244999999999
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.008151245	0.8151244999999999
LATERAL MENINGOCELE SYNDROME	0.008151245	0.8151244999999999
DESANTO-SHINAWI SYNDROME	0.008069554	0.8069554
FLOATING-HARBOR SYNDROME	0.008069554	0.8069554
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.008	0.8
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.008	0.8
NIJMEGEN BREAKAGE SYNDROME	0.008	0.8
TRISOMY 18P	0.008	0.8
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.008	0.8
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.008	0.8
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.008	0.8
MEHMO SYNDROME	0.008	0.8
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.008	0.8
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.008	0.8
CERNUNNOS-XLF DEFICIENCY	0.008	0.8
BOWEN-CONRADI SYNDROME	0.008	0.8
3-HYDROXYISOBUTYRIC ACIDURIA	0.008	0.8
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.008	0.8
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.008	0.8
MICROHYDRANENCEPHALY; MHAC	0.008	0.8
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.008	0.8
RING CHROMOSOME 8 SYNDROME	0.008	0.8
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.008	0.8
CZEIZEL-LOSONCI SYNDROME	0.008	0.8
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.008	0.8
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.008	0.8
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.008	0.8
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.008	0.8
AMISH LETHAL MICROCEPHALY	0.008	0.8
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.008	0.8
14Q11.2 MICRODELETION SYNDROME	0.008	0.8
MICROCEPHALY, AUTOSOMAL DOMINANT	0.008	0.8
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.008	0.8
ANONYCHIA-MICROCEPHALY SYNDROME	0.008	0.8
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.008	0.8
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.008	0.8
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.008	0.8
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.008	0.8
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.008	0.8
BANGSTAD SYNDROME	0.008	0.8
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.008	0.8
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.008	0.8
ACROCALLOSAL SYNDROME	0.008	0.8
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.008	0.8
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.008	0.8
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.007770104999999999	0.7770104999999999
MEVALONIC ACIDURIA; MEVA	0.007701774	0.7701774
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.007701774	0.7701774
NOONAN SYNDROME 11; NS11	0.007701774	0.7701774
CREE MENTAL RETARDATION SYNDROME	0.007701774	0.7701774
ELSAHY-WATERS SYNDROME; ESWS	0.007701774	0.7701774
RAINE SYNDROME	0.007701774	0.7701774
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.007701774	0.7701774
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.007701774	0.7701774
NOONAN SYNDROME 3; NS3	0.007701774	0.7701774
AL KAISSI SYNDROME; ALKAS	0.007701774	0.7701774
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.007701774	0.7701774
JOUBERT SYNDROME 14	0.007701774	0.7701774
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.007701774	0.7701774
TRISOMY 8P	0.0075239999999999994	0.7524
MOWAT-WILSON SYNDROME	0.0075239999999999994	0.7524
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0073206339999999995	0.7320633999999999
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0073206339999999995	0.7320633999999999
RUBINSTEIN-TAYBI SYNDROME	0.0073206339999999995	0.7320633999999999
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0073206339999999995	0.7320633999999999
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0073206339999999995	0.7320633999999999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0073206339999999995	0.7320633999999999
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00715622	0.715622
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00715622	0.715622
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00715622	0.715622
AYME-GRIPP SYNDROME; AYGRP	0.00715622	0.715622
ACRORENAL-MANDIBULAR SYNDROME	0.00715622	0.715622
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00715622	0.715622
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00715622	0.715622
SCARF SYNDROME	0.00715622	0.715622
PHAVER SYNDROME	0.00715622	0.715622
MEIER-GORLIN SYNDROME 3; MGORS3	0.00715622	0.715622
20P13 MICRODELETION SYNDROME	0.00715622	0.715622
GABRIELE-DE VRIES SYNDROME	0.00715622	0.715622
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.006917059	0.6917059
SHASHI-PENA SYNDROME; SHAPNS	0.006891749	0.6891749
C SYNDROME	0.006891749	0.6891749
RECOMBINANT CHROMOSOME 8 SYNDROME	0.006891749	0.6891749
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.006891749	0.6891749
CHROMOSOME 9P DELETION SYNDROME	0.006891749	0.6891749
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.006891749	0.6891749
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.006891749	0.6891749
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.006891749	0.6891749
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0065106090000000005	0.6510609
EMANUEL SYNDROME	0.0065106090000000005	0.6510609
SCHAAF-YANG SYNDROME; SHFYNG	0.0065106090000000005	0.6510609
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0065106090000000005	0.6510609
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.006346195	0.6346195
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.006346195	0.6346195
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.006346195	0.6346195
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.006346195	0.6346195
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.006346195	0.6346195
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.006346195	0.6346195
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.006346195	0.6346195
NOONAN SYNDROME 2; NS2	0.006303174	0.6303174
DONNAI-BARROW SYNDROME	0.006303174	0.6303174
GABRIELE-DE VRIES SYNDROME; GADEVS	0.006303174	0.6303174
FRIAS SYNDROME	0.006303174	0.6303174
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.006303174	0.6303174
14Q22Q23 MICRODELETION SYNDROME	0.006303174	0.6303174
MONOSOMY 13Q34	0.006303174	0.6303174
%300712 CRANIOFACIOSKELETAL SYNDROME	0.006303174	0.6303174
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.006303174	0.6303174
KAPUR-TORIELLO SYNDROME	0.005965055	0.5965055
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.0059220340000000005	0.5922034
COFFIN-SIRIS SYNDROME 6; CSS6	0.0059220340000000005	0.5922034
FRONTOOCULAR SYNDROME	0.005896724	0.5896724
PERLMAN SYNDROME	0.005896724	0.5896724
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.005896724	0.5896724
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.005896724	0.5896724
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.005896724	0.5896724
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.005896724	0.5896724
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.005896724	0.5896724
11Q22.2Q22.3 MICRODELETION SYNDROME	0.005896724	0.5896724
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.005896724	0.5896724
TARP SYNDROME; TARPS	0.005896724	0.5896724
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.005896724	0.5896724
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.005896724	0.5896724
OROFACIODIGITAL SYNDROME XIV; OFD14	0.005896724	0.5896724
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.005896724	0.5896724
CHROMOSOME 16Q22 DELETION SYNDROME	0.005896724	0.5896724
TETRASOMY 5P	0.005896724	0.5896724
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.005896724	0.5896724
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.005896724	0.5896724
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.005896724	0.5896724
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.005896724	0.5896724
OROFACIODIGITAL SYNDROME VI	0.005896724	0.5896724
PEROXISOME BIOGENESIS DISORDER 10B	0.005896724	0.5896724
WALKER-WARBURG SYNDROME	0.005896724	0.5896724
HARTSFIELD SYNDROME; HRTFDS	0.005896724	0.5896724
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.005896724	0.5896724
CHROMOSOME 15Q14 DELETION SYNDROME	0.005896724	0.5896724
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.005896724	0.5896724
OROFACIODIGITAL SYNDROME TYPE 4	0.005896724	0.5896724
EAR-PATELLA-SHORT STATURE SYNDROME	0.005896724	0.5896724
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.005896724	0.5896724
HADZISELIMOVIC SYNDROME	0.005896724	0.5896724
CONGENITAL HYDROCEPHALUS	0.00575762	0.575762
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00575762	0.575762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00575762	0.575762
MEIER-GORLIN SYNDROME 6; MGORS6	0.00575762	0.575762
ACROCALLOSAL SYNDROME; ACLS	0.00575762	0.575762
MARTSOLF SYNDROME	0.00575762	0.575762
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00575762	0.575762
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00537648	0.537648
AUTISM, SUSCEPTIBILITY TO, 18	0.00537648	0.537648
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00537648	0.537648
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00535117	0.535117
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00535117	0.535117
PSEUDOTRISOMY 13 SYNDROME	0.00535117	0.535117
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00535117	0.535117
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00535117	0.535117
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00535117	0.535117
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00535117	0.535117
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00535117	0.535117
SIMOSA CRANIOFACIAL SYNDROME	0.00535117	0.535117
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00535117	0.535117
WIDOW'S PEAK SYNDROME	0.00535117	0.535117
FEINGOLD SYNDROME 1; FGLDS1	0.00535117	0.535117
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00535117	0.535117
DIAMOND-BLACKFAN ANEMIA 10	0.00535117	0.535117
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00535117	0.535117
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00535117	0.535117
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00535117	0.535117
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00535117	0.535117
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00535117	0.535117
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00535117	0.535117
OTOONYCHOPERONEAL SYNDROME	0.00535117	0.535117
COG5-CDG	0.00535117	0.535117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00535117	0.535117
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00535117	0.535117
CEREBROOCULONASAL SYNDROME	0.00535117	0.535117
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00535117	0.535117
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00535117	0.535117
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00535117	0.535117
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00535117	0.535117
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00535117	0.535117
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00535117	0.535117
SPONDYLOOCULAR SYNDROME; SOS	0.00535117	0.535117
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.00535117	0.535117
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00535117	0.535117
BRANCHIOOCULOFACIAL SYNDROME	0.00535117	0.535117
COFFIN-SIRIS SYNDROME 10; CSS10	0.00535117	0.535117
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00535117	0.535117
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00535117	0.535117
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00535117	0.535117
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00535117	0.535117
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005112009000000001	0.5112009000000001
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005112009000000001	0.5112009000000001
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.005112009000000001	0.5112009000000001
49,XXXXY SYNDROME	0.005112009000000001	0.5112009000000001
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.005112009000000001	0.5112009000000001
48,XXXY SYNDROME	0.005112009000000001	0.5112009000000001
SMITH-MAGENIS SYNDROME; SMS	0.005112009000000001	0.5112009000000001
HOLOPROSENCEPHALY 2; HPE2	0.005112009000000001	0.5112009000000001
48,XXYY SYNDROME	0.005112009000000001	0.5112009000000001
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.005112009000000001	0.5112009000000001
PITT-HOPKINS SYNDROME	0.005112009000000001	0.5112009000000001
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.005112009000000001	0.5112009000000001
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.005112009000000001	0.5112009000000001
SMITH-MAGENIS SYNDROME	0.005112009000000001	0.5112009000000001
KLEEFSTRA SYNDROME	0.005112009	0.5112009
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.005112009	0.5112009
1P36 DELETION SYNDROME	0.005112009	0.5112009
HOLOPROSENCEPHALY	0.005112009	0.5112009
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00497003	0.49700300000000003
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00497003	0.49700300000000003
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.004947595	0.4947595
ZIMMERMANN-LABAND SYNDROME 1	0.004947595	0.4947595
MICROTRIPLICATION 11Q24.1	0.004947595	0.4947595
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.004947595	0.4947595
BRADDOCK SYNDROME	0.004947595	0.4947595
FETAL AKINESIA DEFORMATION SEQUENCE	0.004947595	0.4947595
MONOSOMY 9P	0.004744229	0.4744229
ZTTK SYNDROME; ZTTKS	0.004744229	0.4744229
OGDEN SYNDROME; OGDNS	0.004744229	0.4744229
OTOPALATODIGITAL SYNDROME TYPE 2	0.004744229	0.4744229
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.004744229	0.4744229
CUTIS LAXA	0.004744229	0.4744229
COHEN-GIBSON SYNDROME; COGIS	0.004744229	0.4744229
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.004744229	0.4744229
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.004744229	0.4744229
3C SYNDROME	0.004744229	0.4744229
DISTAL MONOSOMY 6P	0.004744229	0.4744229
OGDEN SYNDROME	0.004744229	0.4744229
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.004744229	0.4744229
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.004744229	0.4744229
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.004744229	0.4744229
ALEXANDER DISEASE	0.0045664550000000005	0.45664550000000004
PRUNE BELLY SYNDROME	0.0045664550000000005	0.45664550000000004
WILLIAMS SYNDROME	0.0045664550000000005	0.45664550000000004
RETT SYNDROME, CONGENITAL VARIANT	0.0045664550000000005	0.45664550000000004
LOWE OCULOCEREBRORENAL SYNDROME	0.0045664550000000005	0.45664550000000004
OCULOCEREBRORENAL SYNDROME OF LOWE	0.0045664550000000005	0.45664550000000004
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0045664550000000005	0.45664550000000004
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0045664550000000005	0.45664550000000004
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0045664550000000005	0.45664550000000004
AICARDI SYNDROME	0.0045664550000000005	0.45664550000000004
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0045664550000000005	0.45664550000000004
RETT SYNDROME; RTT	0.0045664550000000005	0.45664550000000004
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0045664550000000005	0.45664550000000004
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0045664550000000005	0.45664550000000004
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.004498124	0.4498124
MACDERMOT-WINTER SYNDROME	0.004498124	0.4498124
IMMUNODEFICIENCY 49; IMD49	0.004498124	0.4498124
PALLISTER-HALL SYNDROME	0.004498124	0.4498124
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004498124	0.4498124
11P15.4 MICRODUPLICATION SYNDROME	0.004498124	0.4498124
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004498124	0.4498124
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.004498124	0.4498124
CORNELIA DE LANGE SYNDROME 3	0.004498124	0.4498124
HYPOTONIA-CYSTINURIA SYNDROME	0.004498124	0.4498124
CK SYNDROME	0.004498124	0.4498124
8Q24.3 MICRODELETION SYNDROME	0.004498124	0.4498124
HALLERMANN-STREIFF SYNDROME; HSS	0.004198675	0.4198675
ACROOSTEOLYSIS DOMINANT TYPE	0.004198675	0.4198675
CRI-DU-CHAT SYNDROME	0.004198675	0.4198675
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.004198675	0.4198675
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004198675	0.4198675
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.004198675	0.4198675
15Q26 OVERGROWTH SYNDROME	0.004198675	0.4198675
NOONAN SYNDROME 7; NS7	0.004198675	0.4198675
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.004198675	0.4198675
GENITOPALATOCARDIAC SYNDROME	0.004198675	0.4198675
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.004198675	0.4198675
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.004198675	0.4198675
3MC SYNDROME	0.004198675	0.4198675
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.004198675	0.4198675
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.004198675	0.4198675
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.004198675	0.4198675
PROTEUS SYNDROME	0.004198675	0.4198675
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.004198675	0.4198675
THYROID HYPOPLASIA	0.004116984	0.41169839999999996
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004116984	0.41169839999999996
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004116984	0.41169839999999996
INFANTILE DYSTONIA-PARKINSONISM	0.004116984	0.41169839999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004116984	0.41169839999999996
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004116984	0.41169839999999996
NEPHROGENIC DIABETES INSIPIDUS	0.004116984	0.41169839999999996
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004116984	0.41169839999999996
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004116984	0.41169839999999996
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.004116984	0.41169839999999996
PROPIONIC ACIDEMIA	0.004116984	0.41169839999999996
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004116984	0.41169839999999996
300270 ADRENOMYODYSTROPHY	0.004116984	0.41169839999999996
XQ28 (MECP2) DUPLICATION	0.004116984	0.41169839999999996
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004116984	0.41169839999999996
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004116984	0.41169839999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004116984	0.41169839999999996
NIEMANN-PICK DISEASE, TYPE A	0.004116984	0.41169839999999996
THYROID HEMIAGENESIS	0.004116984	0.41169839999999996
PROPIONIC ACIDEMIA	0.004116984	0.41169839999999996
PRADER-WILLI-LIKE SYNDROME	0.004116984	0.41169839999999996
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004116984	0.41169839999999996
FAMILIAL THYROID DYSHORMONOGENESIS	0.004116984	0.41169839999999996
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004116984	0.41169839999999996
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004116984	0.41169839999999996
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.004116984	0.41169839999999996
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.004116984	0.41169839999999996
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.004116984	0.41169839999999996
CONGENITAL HYPOTHYROIDISM	0.004116984	0.41169839999999996
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004116984	0.41169839999999996
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004116984	0.41169839999999996
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004116984	0.41169839999999996
PERIPHERAL HYPOTHYROIDISM	0.004116984	0.41169839999999996
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.004116984	0.41169839999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.41169839999999996
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004116984	0.41169839999999996
THYROID ECTOPIA	0.004116984	0.41169839999999996
ATHYREOSIS	0.004116984	0.41169839999999996
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004116984	0.41169839999999996
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.004116984	0.41169839999999996
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00395257	0.39525699999999997
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00395257	0.39525699999999997
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00395257	0.39525699999999997
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.00395257	0.39525699999999997
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00395257	0.39525699999999997
PENILE AGENESIS	0.00395257	0.39525699999999997
FLOATING-HARBOR SYNDROME	0.00395257	0.39525699999999997
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00395257	0.39525699999999997
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00395257	0.39525699999999997
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.00395257	0.39525699999999997
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.00395257	0.39525699999999997
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00395257	0.39525699999999997
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00395257	0.39525699999999997
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00395257	0.39525699999999997
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00395257	0.39525699999999997
600736 VELOFACIOSKELETAL SYNDROME	0.00395257	0.39525699999999997
JOUBERT SYNDROME 10	0.003749204	0.3749204
RING CHROMOSOME 14 SYNDROME	0.003749204	0.3749204
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.003749204	0.3749204
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.003749204	0.3749204
16P13.11 MICRODELETION SYNDROME	0.003749204	0.3749204
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.003749204	0.3749204
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.003749204	0.3749204
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003749204	0.3749204
TEMTAMY SYNDROME; TEMTYS	0.003749204	0.3749204
16P11.2P12.2 MICRODELETION SYNDROME	0.003749204	0.3749204
XIA-GIBBS SYNDROME	0.003749204	0.3749204
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.003749204	0.3749204
RITSCHER-SCHINZEL SYNDROME 1	0.003749204	0.3749204
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.003749204	0.3749204
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.003749204	0.3749204
CHROMOSOME 10Q26 DELETION SYNDROME	0.003749204	0.3749204
GOLDBERG-SHPRINTZEN SYNDROME	0.003749204	0.3749204
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.003749204	0.3749204
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.003749204	0.3749204
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.003749204	0.3749204
8P23.1 MICRODELETION SYNDROME	0.003749204	0.3749204
MAN1B1-CDG	0.003749204	0.3749204
MONOSOMY 9Q22.3	0.003749204	0.3749204
3Q29 MICRODUPLICATION SYNDROME	0.003749204	0.3749204
2Q32Q33 MICRODELETION SYNDROME	0.003749204	0.3749204
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.003749204	0.3749204
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.003749204	0.3749204
DE BARSY SYNDROME	0.003749204	0.3749204
GLASS SYNDROME	0.003749204	0.3749204
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.003749204	0.3749204
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.003749204	0.3749204
WRINKLY SKIN SYNDROME	0.003749204	0.3749204
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.003749204	0.3749204
17P13.3 MICRODUPLICATION SYNDROME	0.003749204	0.3749204
DISTAL MONOSOMY 12Q	0.003749204	0.3749204
NOONAN SYNDROME 5; NS5	0.003749204	0.3749204
10Q22.3Q23.3 MICRODELETION SYNDROME	0.003749204	0.3749204
3Q29 MICRODELETION SYNDROME	0.003749204	0.3749204
ADIPOSIS DOLOROSA	0.00357143	0.357143
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.357143
PORPHYRIA VARIEGATA	0.00357143	0.357143
HIRSCHSPRUNG DISEASE	0.00357143	0.357143
UROFACIAL SYNDROME 2	0.00357143	0.357143
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.357143
MULTIPLE SYSTEM ATROPHY	0.00357143	0.357143
HYPOPHOSPHATASIA, INFANTILE	0.00357143	0.357143
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.357143
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.357143
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.357143
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00357143	0.357143
HINMAN SYNDROME	0.00357143	0.357143
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00357143	0.357143
ADDISON DISEASE	0.00357143	0.357143
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.357143
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.00357143	0.357143
MYXEDEMA	0.00357143	0.357143
GITELMAN SYNDROME	0.00357143	0.357143
C SYNDROME	0.00357143	0.357143
SOMATOSTATINOMA	0.00357143	0.357143
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.357143
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.357143
ACUTE INTERMITTENT PORPHYRIA	0.00357143	0.357143
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.357143
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.357143
UROFACIAL SYNDROME	0.00357143	0.357143
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.357143
TYPHOID	0.00357143	0.357143
TEMPLE-BARAITSER SYNDROME	0.00357143	0.357143
POLYMYOSITIS	0.00357143	0.357143
PORPHYRIA	0.00357143	0.357143
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.357143
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.357143
FOODBORNE BOTULISM	0.00357143	0.357143
HEREDITARY COPROPORPHYRIA	0.00357143	0.357143
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.357143
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.357143
2Q23.1 MICRODELETION SYNDROME	0.00357143	0.357143
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.357143
WILLIAMS-BEUREN SYNDROME; WBS	0.00357143	0.357143
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.357143
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00357143	0.357143
GLUCAGONOMA	0.00357143	0.357143
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.357143
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.357143
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.357143
LYNCH SYNDROME	0.00357143	0.357143
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.357143
RHEUMATIC FEVER	0.00357143	0.357143
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.357143
GITELMAN SYNDROME	0.00357143	0.357143
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00357143	0.357143
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.357143
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.357143
WOUND BOTULISM	0.00357143	0.357143
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.357143
JUVENILE DERMATOMYOSITIS	0.00357143	0.357143
DDOST-CDG	0.00357143	0.357143
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00357143	0.357143
INFANT BOTULISM	0.00357143	0.357143
FG SYNDROME 2; FGS2	0.00357143	0.357143
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.357143
ACUTE ADRENAL INSUFFICIENCY	0.00357143	0.357143
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.357143
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.357143
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00357143	0.357143
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.357143
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.357143
BOTULISM	0.00357143	0.357143
OCHOA SYNDROME	0.00357143	0.357143
PSEUDOMYXOMA PERITONEI	0.00357143	0.357143
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.357143
SHEEHAN SYNDROME	0.00357143	0.357143
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.357143
FAMILIAL MEDITERRANEAN FEVER	0.00357143	0.357143
PPOMA	0.00357143	0.357143
NK-CELL ENTEROPATHY	0.00357143	0.357143
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.357143
ATTRV30M AMYLOIDOSIS	0.00357143	0.357143
TOWNES-BROCKS SYNDROME	0.00357143	0.357143
VISCERAL MYOPATHY; VSCM	0.00357143	0.357143
GRFOMA	0.00357143	0.357143
ADIPOSIS DOLOROSA	0.00357143	0.357143
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.357143
PARATHYROID CARCINOMA	0.00357143	0.357143
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00357143	0.357143
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.357143
WAARDENBURG-SHAH SYNDROME	0.00357143	0.357143
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.357143
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.00357143	0.357143
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.357143
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00357143	0.357143
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00357143	0.357143
PANHYPOPITUITARISM	0.00357143	0.357143
WOLFRAM SYNDROME	0.00357143	0.357143
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00357143	0.357143
HEREDITARY FRUCTOSE INTOLERANCE	0.00357143	0.357143
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00357143	0.357143
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.357143
IATROGENIC BOTULISM	0.00357143	0.357143
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00357143	0.357143
NEUROFERRITINOPATHY	0.00357143	0.357143
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.357143
INHALATIONAL BOTULISM	0.00357143	0.357143
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00357143	0.357143
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.357143
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00357143	0.357143
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00357143	0.357143
CAP POLYPOSIS	0.00357143	0.357143
PORPHYRIA VARIEGATA	0.00357143	0.357143
ERYTHERMALGIA, PRIMARY	0.00357143	0.357143
MELAS	0.00357143	0.357143
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.357143
PURE AUTONOMIC FAILURE	0.00357143	0.357143
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00357143	0.357143
PUDENDAL NEURALGIA	0.00357143	0.357143
MALT LYMPHOMA	0.00357143	0.357143
PAROXYSMAL EXTREME PAIN DISORDER	0.00357143	0.357143
FAMILIAL COLORECTAL CANCER TYPE X	0.00357143	0.357143
LIDDLE SYNDROME	0.00357143	0.357143
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.357143
SMITH-LEMLI-OPITZ SYNDROME	0.003345629	0.3345629
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.003345629	0.3345629
AARSKOG-SCOTT SYNDROME	0.003345629	0.3345629
17P11.2 MICRODUPLICATION SYNDROME	0.003345629	0.3345629
OCCIPITAL HORN SYNDROME	0.003345629	0.3345629
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.003345629	0.3345629
COHEN SYNDROME	0.003345629	0.3345629
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.003345629	0.3345629
22Q11.2 MICRODUPLICATION SYNDROME	0.003345629	0.3345629
WEAVER SYNDROME	0.003345629	0.3345629
COLE-CARPENTER SYNDROME	0.003345629	0.3345629
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.003345629	0.3345629
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.003345629	0.3345629
SIMPSON-GOLABI-BEHMEL SYNDROME	0.003345629	0.3345629
15Q24 MICRODELETION SYNDROME	0.003345629	0.3345629
TRISOMY 9P	0.003345629	0.3345629
RUVALCABA SYNDROME	0.003345629	0.3345629
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.003345629	0.3345629
SOTOS SYNDROME	0.003345629	0.3345629
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.003345629	0.3345629
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.003345629	0.3345629
POTOCKI-LUPSKI SYNDROME	0.003345629	0.3345629
CHROMOSOME 16P13.3 DELETION SYNDROME	0.003345629	0.3345629
WOLF-HIRSCHHORN SYNDROME	0.003345629	0.3345629
WEAVER SYNDROME	0.003345629	0.3345629
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.003345629	0.3345629
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.003345629	0.3345629
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0032036499999999997	0.32036499999999996
NEONATAL MARFAN SYNDROME	0.0032036499999999997	0.32036499999999996
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0032036499999999997	0.32036499999999996
FIBROCHONDROGENESIS	0.0032036499999999997	0.32036499999999996
FRANK-TER HAAR SYNDROME; FTHS	0.0032036499999999997	0.32036499999999996
21Q22.11Q22.12 MICRODELETION SYNDROME	0.0032036499999999997	0.32036499999999996
8Q21.11 MICRODELETION SYNDROME	0.0032036499999999997	0.32036499999999996
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.0032036499999999997	0.32036499999999996
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0032036499999999997	0.32036499999999996
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0032036499999999997	0.32036499999999996
NOONAN SYNDROME 8; NS8	0.0032036499999999997	0.32036499999999996
ACROOTOOCULAR SYNDROME	0.0032036499999999997	0.32036499999999996
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0032036499999999997	0.32036499999999996
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0032036499999999997	0.32036499999999996
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0032036499999999997	0.32036499999999996
THANATOPHORIC DYSPLASIA	0.0032036499999999997	0.32036499999999996
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0032036499999999997	0.32036499999999996
NEUROFACIODIGITORENAL SYNDROME	0.0032036499999999997	0.32036499999999996
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0032036499999999997	0.32036499999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0032036499999999997	0.32036499999999996
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.0032036499999999997	0.32036499999999996
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0032036499999999997	0.32036499999999996
DISTAL TRISOMY 5Q	0.0032036499999999997	0.32036499999999996
RING CHROMOSOME 10 SYNDROME	0.0032036499999999997	0.32036499999999996
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0032036499999999997	0.32036499999999996
LOWRY-MACLEAN SYNDROME	0.0032036499999999997	0.32036499999999996
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.0032036499999999997	0.32036499999999996
JUVENILE POLYPOSIS SYNDROME	0.0032036499999999997	0.32036499999999996
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0032036499999999997	0.32036499999999996
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.0032036499999999997	0.32036499999999996
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0032036499999999997	0.32036499999999996
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0032036499999999997	0.32036499999999996
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0032036499999999997	0.32036499999999996
CRANIOFACIAL DYSSYNOSTOSIS	0.0032036499999999997	0.32036499999999996
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0032036499999999997	0.32036499999999996
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0032036499999999997	0.32036499999999996
TRISOMY 1Q	0.0032036499999999997	0.32036499999999996
RESTRICTIVE DERMOPATHY	0.0032036499999999997	0.32036499999999996
MOSAIC TRISOMY 1	0.0032036499999999997	0.32036499999999996
3Q27.3 MICRODELETION SYNDROME	0.0032036499999999997	0.32036499999999996
JUVENILE POLYPOSIS OF INFANCY	0.0032036499999999997	0.32036499999999996
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0032036499999999997	0.32036499999999996
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0032036499999999997	0.32036499999999996
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0032036499999999997	0.32036499999999996
TRICHOHEPATOENTERIC SYNDROME 1	0.0032036499999999997	0.32036499999999996
HYPERTELORISM, TEEBI TYPE	0.0032036499999999997	0.32036499999999996
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.002939179	0.2939179
WIEACKER-WOLFF SYNDROME	0.002939179	0.2939179
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.002939179	0.2939179
19P13.12 MICRODELETION SYNDROME	0.002939179	0.2939179
RECOMBINANT 8 SYNDROME	0.002939179	0.2939179
JABERI-ELAHI SYNDROME; JABELS	0.002939179	0.2939179
AICARDI-GOUTIÈRES SYNDROME	0.002939179	0.2939179
DIGEORGE SYNDROME; DGS	0.002939179	0.2939179
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002939179	0.2939179
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002939179	0.2939179
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002939179	0.2939179
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002939179	0.2939179
CEREBELLOFACIODENTAL SYNDROME	0.002939179	0.2939179
BRESEK SYNDROME	0.002939179	0.2939179
FETAL TRIMETHADIONE SYNDROME	0.002939179	0.2939179
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.002939179	0.2939179
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002939179	0.2939179
MOSAIC TRISOMY 9	0.002939179	0.2939179
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.002939179	0.2939179
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.002939179	0.2939179
15Q14 MICRODELETION SYNDROME	0.002939179	0.2939179
ALAZAMI SYNDROME; ALAZS	0.002939179	0.2939179
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.002939179	0.2939179
RUVALCABA SYNDROME	0.002800075	0.2800075
MACS SYNDROME	0.002800075	0.2800075
NON-DISTAL TRISOMY 10Q	0.002800075	0.2800075
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.002800075	0.2800075
17Q24.2 MICRODELETION SYNDROME	0.002800075	0.2800075
RIN2 SYNDROME	0.002800075	0.2800075
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.002800075	0.2800075
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.002800075	0.2800075
FRONTOMETAPHYSEAL DYSPLASIA	0.002800075	0.2800075
CRANIOFRONTONASAL DYSPLASIA	0.002800075	0.2800075
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.002800075	0.2800075
MONOSOMY 5P	0.002800075	0.2800075
CENANI-LENZ SYNDROME	0.002800075	0.2800075
CHROMOSOME 17Q12 DELETION SYNDROME	0.002800075	0.2800075
CAREY-FINEMAN-ZITER SYNDROME	0.002800075	0.2800075
ATKIN-FLAITZ SYNDROME	0.002800075	0.2800075
TETRASOMY 18P	0.002800075	0.2800075
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.002800075	0.2800075
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.002800075	0.2800075
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.002800075	0.2800075
SECKEL SYNDROME	0.002800075	0.2800075
CEREBROFACIOTHORACIC DYSPLASIA	0.002800075	0.2800075
CHROMOSOME 18Q DELETION SYNDROME	0.002800075	0.2800075
SOTOS SYNDROME 2	0.002800075	0.2800075
FRANK-TER HAAR SYNDROME	0.002800075	0.2800075
NOONAN SYNDROME	0.002800075	0.2800075
ACRO-RENAL-MANDIBULAR SYNDROME	0.002800075	0.2800075
TRISOMY 20P	0.002800075	0.2800075
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.002800075	0.2800075
CLARK-BARAITSER SYNDROME	0.002800075	0.2800075
15Q OVERGROWTH SYNDROME	0.002800075	0.2800075
XP22.13P22.2 DUPLICATION SYNDROME	0.002800075	0.2800075
NOONAN SYNDROME 4; NS4	0.002800075	0.2800075
FREEMAN-SHELDON SYNDROME	0.002800075	0.2800075
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.002800075	0.2800075
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.002800075	0.2800075
FRONTOMETAPHYSEAL DYSPLASIA	0.002800075	0.2800075
CHARGE SYNDROME	0.002800075	0.2800075
3P25.3 MICRODELETION SYNDROME	0.002800075	0.2800075
MARFAN SYNDROME	0.002800075	0.2800075
MALAN OVERGROWTH SYNDROME	0.002800075	0.2800075
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.002800075	0.2800075
TRISOMY 13	0.002393625	0.23936249999999998
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.002393625	0.23936249999999998
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.002393625	0.23936249999999998
4Q21 MICRODELETION SYNDROME	0.002393625	0.23936249999999998
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.002393625	0.23936249999999998
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.002393625	0.23936249999999998
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.002393625	0.23936249999999998
TURNER SYNDROME	0.002393625	0.23936249999999998
FOCAL DERMAL HYPOPLASIA; FDH	0.002393625	0.23936249999999998
MOSAIC MONOSOMY X	0.002393625	0.23936249999999998
MARDEN-WALKER SYNDROME	0.002393625	0.23936249999999998
CONO-SPONDYLAR DYSPLASIA	0.002393625	0.23936249999999998
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.002393625	0.23936249999999998
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.002393625	0.23936249999999998
CAMPOMELIC DYSPLASIA	0.002393625	0.23936249999999998
MONOSOMY X	0.002393625	0.23936249999999998
FEMORAL-FACIAL SYNDROME	0.002393625	0.23936249999999998
STUVE-WIEDEMANN SYNDROME	0.002393625	0.23936249999999998
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.002393625	0.23936249999999998
MARSHALL-SMITH SYNDROME; MRSHSS	0.002393625	0.23936249999999998
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.002393625	0.23936249999999998
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.002393625	0.23936249999999998
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.002393625	0.23936249999999998
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.002393625	0.23936249999999998
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.002393625	0.23936249999999998
NEMALINE MYOPATHY 2; NEM2	0.002393625	0.23936249999999998
FOCAL DERMAL HYPOPLASIA	0.002393625	0.23936249999999998
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.002393625	0.23936249999999998
ATELOSTEOGENESIS TYPE I	0.002393625	0.23936249999999998
SAETHRE-CHOTZEN SYNDROME	0.002393625	0.23936249999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.002350604	0.2350604
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002350604	0.2350604
GERMAN SYNDROME	0.002350604	0.2350604
CRANIOFRONTONASAL SYNDROME; CFNS	0.002350604	0.2350604
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002350604	0.2350604
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.002350604	0.2350604
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.002350604	0.2350604
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002350604	0.2350604
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002350604	0.2350604
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002350604	0.2350604
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002350604	0.2350604
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002350604	0.2350604
HYPERTRICHOSIS CUBITI	0.002350604	0.2350604
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.002350604	0.2350604
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002350604	0.2350604
15Q13.3 MICRODELETION SYNDROME	0.002350604	0.2350604
SHUKLA-VERNON SYNDROME; SHUVER	0.002350604	0.2350604
GABA-TRANSAMINASE DEFICIENCY	0.002350604	0.2350604
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.002350604	0.2350604
3MC SYNDROME 2	0.002350604	0.2350604
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.002350604	0.2350604
CHAR SYNDROME	0.002350604	0.2350604
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.002350604	0.2350604
MONOSOMY 18Q	0.002350604	0.2350604
TONNE-KALSCHEUER SYNDROME; TOKAS	0.002350604	0.2350604
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.2350604
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.002350604	0.2350604
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002350604	0.2350604
GENITOPATELLAR SYNDROME; GTPTS	0.002350604	0.2350604
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002350604	0.2350604
6Q25 MICRODELETION SYNDROME	0.002350604	0.2350604
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.002350604	0.2350604
W SYNDROME	0.002350604	0.2350604
TREACHER-COLLINS SYNDROME	0.002350604	0.2350604
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.002350604	0.2350604
TETRASOMY 9P	0.002350604	0.2350604
CHROMOSOME 15Q25 DELETION SYNDROME	0.002350604	0.2350604
15Q11Q13 MICRODUPLICATION SYNDROME	0.002350604	0.2350604
20P12.3 MICRODELETION SYNDROME	0.002350604	0.2350604
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.002350604	0.2350604
LUSCAN-LUMISH SYNDROME; LLS	0.002350604	0.2350604
CHROMOSOME 17P13.1 DELETION SYNDROME	0.002350604	0.2350604
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.002350604	0.2350604
THAUVIN-ROBINET-FAIVRE SYNDROME	0.002350604	0.2350604
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.002350604	0.2350604
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002350604	0.2350604
MUENKE SYNDROME	0.002350604	0.2350604
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.002350604	0.2350604
MEVALONIC ACIDURIA	0.002350604	0.2350604
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002350604	0.2350604
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.002350604	0.2350604
NOONAN SYNDROME 9; NS9	0.002350604	0.2350604
FILIPPI SYNDROME	0.002350604	0.2350604
HEREDITARY OROTIC ACIDURIA	0.002350604	0.2350604
PALLISTER-HALL SYNDROME	0.002350604	0.2350604
CEDNIK SYNDROME	0.002350604	0.2350604
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.002350604	0.2350604
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002350604	0.2350604
6Q16 MICRODELETION SYNDROME	0.0019441539999999998	0.1944154
DIAPHANOSPONDYLODYSOSTOSIS	0.0019441539999999998	0.1944154
TEMTAMY SYNDROME	0.0019441539999999998	0.1944154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0019441539999999998	0.1944154
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0019441539999999998	0.1944154
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0019441539999999998	0.1944154
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0019441539999999998	0.1944154
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0019441539999999998	0.1944154
CHAR SYNDROME	0.0019441539999999998	0.1944154
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0019441539999999998	0.1944154
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0019441539999999998	0.1944154
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0019441539999999998	0.1944154
LARSEN-LIKE SYNDROME	0.0019441539999999998	0.1944154
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0019441539999999998	0.1944154
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0019441539999999998	0.1944154
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0019441539999999998	0.1944154
HOLMES-GANG SYNDROME	0.0019441539999999998	0.1944154
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0019441539999999998	0.1944154
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0019441539999999998	0.1944154
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0019441539999999998	0.1944154
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0019441539999999998	0.1944154
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0019441539999999998	0.1944154
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0019441539999999998	0.1944154
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0019441539999999998	0.1944154
VICI SYNDROME; VICIS	0.0019441539999999998	0.1944154
DISTAL MONOSOMY 15Q	0.0019441539999999998	0.1944154
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0019441539999999998	0.1944154
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0019441539999999998	0.1944154
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0019441539999999998	0.1944154
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0019441539999999998	0.1944154
8Q22.1 MICRODELETION SYNDROME	0.0019441539999999998	0.1944154
JOUBERT SYNDROME 2	0.0019441539999999998	0.1944154
DISTAL MONOSOMY 1Q	0.0019441539999999998	0.1944154
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0019441539999999998	0.1944154
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0019441539999999998	0.1944154
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0019441539999999998	0.1944154
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0019441539999999998	0.1944154
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0019441539999999998	0.1944154
GENITOPATELLAR SYNDROME	0.0019441539999999998	0.1944154
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0019441539999999998	0.1944154
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0019441539999999998	0.1944154
MEND SYNDROME	0.0019441539999999998	0.1944154
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0019441539999999998	0.1944154
TRISOMY 12P	0.0019441539999999998	0.1944154
BILATERAL POLYMICROGYRIA	0.0019441539999999998	0.1944154
ZECHI-CEIDE SYNDROME	0.0019441539999999998	0.1944154
JOUBERT SYNDROME 35; JBTS35	0.0019441539999999998	0.1944154
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0019441539999999998	0.1944154
RING CHROMOSOME 12 SYNDROME	0.0019441539999999998	0.1944154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0019441539999999998	0.1944154
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.0019441539999999998	0.1944154
TOLUENE EMBRYOPATHY	0.0019441539999999998	0.1944154
CATEL-MANZKE SYNDROME; CATMANS	0.0019441539999999998	0.1944154
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0019441539999999998	0.1944154
YUNIS-VARON SYNDROME	0.0019441539999999998	0.1944154
JOUBERT SYNDROME 1	0.0019441539999999998	0.1944154
DISTAL TRISOMY 6P	0.0019441539999999998	0.1944154
DIAMOND-BLACKFAN ANEMIA 5	0.0019441539999999998	0.1944154
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0019441539999999998	0.1944154
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0019441539999999998	0.1944154
MYHRE SYNDROME	0.0019441539999999998	0.1944154
ICF SYNDROME	0.0019441539999999998	0.1944154
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0019441539999999998	0.1944154
PFEIFFER SYNDROME TYPE 2	0.0019441539999999998	0.1944154
AL-RAQAD SYNDROME; ARS	0.0019441539999999998	0.1944154
MEND SYNDROME; MEND	0.0019441539999999998	0.1944154
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0019441539999999998	0.1944154
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0019441539999999998	0.1944154
PHENOBARBITAL EMBRYOPATHY	0.0019441539999999998	0.1944154
ADAMS-OLIVER SYNDROME 2; AOS2	0.0019441539999999998	0.1944154
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0019441539999999998	0.1944154
GLYCEROL KINASE DEFICIENCY; GKD	0.0019441539999999998	0.1944154
FORSYTHE-WAKELING SYNDROME; FWS	0.0019441539999999998	0.1944154
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0019441539999999998	0.1944154
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0019441539999999998	0.1944154
SIALURIA	0.0019441539999999998	0.1944154
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0019441539999999998	0.1944154
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.1944154
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0019441539999999998	0.1944154
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.1944154
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.180505
PROTEUS-LIKE SYNDROME	0.00180505	0.180505
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00180505	0.180505
PRIMROSE SYNDROME; PRIMS	0.00180505	0.180505
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00180505	0.180505
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.180505
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00180505	0.180505
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00180505	0.180505
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00180505	0.180505
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00180505	0.180505
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.180505
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00180505	0.180505
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.180505
2Q24 MICRODELETION SYNDROME	0.00180505	0.180505
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00180505	0.180505
JOHNSON NEUROECTODERMAL SYNDROME	0.00180505	0.180505
MOMO SYNDROME	0.00180505	0.180505
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00180505	0.180505
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.180505
2P15-16.1 MICRODELETION SYNDROME	0.00180505	0.180505
ALAGILLE SYNDROME	0.00180505	0.180505
DISTAL MONOSOMY 10P	0.00180505	0.180505
BRANCHIOSKELETOGENITAL SYNDROME	0.00180505	0.180505
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00180505	0.180505
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00180505	0.180505
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00180505	0.180505
ANTLEY-BIXLER SYNDROME	0.00180505	0.180505
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00180505	0.180505
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00180505	0.180505
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.180505
MARFAN SYNDROME; MFS	0.00180505	0.180505
PAI SYNDROME	0.00180505	0.180505
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
POTOCKI-SHAFFER SYNDROME	0.00180505	0.180505
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00180505	0.180505
NAGER SYNDROME	0.00180505	0.180505
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00180505	0.180505
BARDET-BIEDL SYNDROME	0.00180505	0.180505
TREACHER COLLINS SYNDROME 2; TCS2	0.00180505	0.180505
20Q13.33 MICRODELETION SYNDROME	0.00180505	0.180505
MAXILLOFACIAL DYSOSTOSIS	0.00180505	0.180505
LOEYS-DIETZ SYNDROME 5	0.00180505	0.180505
DESMOSTEROLOSIS	0.00180505	0.180505
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.180505
ZIMMERMANN-LABAND SYNDROME	0.00180505	0.180505
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00180505	0.180505
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00180505	0.180505
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00180505	0.180505
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00180505	0.180505
COG1-CDG	0.00180505	0.180505
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00180505	0.180505
PROTEUS SYNDROME	0.00180505	0.180505
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00180505	0.180505
CAT-EYE SYNDROME	0.00180505	0.180505
HYPERTELORISM, TEEBI TYPE; TBHS	0.00180505	0.180505
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00180505	0.180505
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00180505	0.180505
NATIVE AMERICAN MYOPATHY	0.00180505	0.180505
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.180505
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00180505	0.180505
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00180505	0.180505
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00180505	0.180505
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00180505	0.180505
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00180505	0.180505
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00180505	0.180505
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00180505	0.180505
ARTERIAL TORTUOSITY SYNDROME	0.00180505	0.180505
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00180505	0.180505
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00180505	0.180505
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00180505	0.180505
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.180505
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00180505	0.180505
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.00180505	0.180505
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00180505	0.180505
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00180505	0.180505
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.180505
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00180505	0.180505
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.180505
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00180505	0.180505
RING CHROMOSOME 1 SYNDROME	0.00180505	0.180505
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00180505	0.180505
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00180505	0.180505
MEESTER-LOEYS SYNDROME; MRLS	0.00180505	0.180505
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00180505	0.180505
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00180505	0.180505
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00180505	0.180505
SCARF SYNDROME	0.00180505	0.180505
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00180505	0.180505
NOONAN SYNDROME 10; NS10	0.00180505	0.180505
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00180505	0.180505
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00180505	0.180505
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.180505
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00180505	0.180505
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00180505	0.180505
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00180505	0.180505
OROFACIODIGITAL SYNDROME TYPE 1	0.00180505	0.180505
ACROCRANIOFACIAL DYSOSTOSIS	0.00180505	0.180505
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00180505	0.180505
TREACHER COLLINS SYNDROME 3; TCS3	0.00180505	0.180505
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00180505	0.180505
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00180505	0.180505
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.180505
APERT SYNDROME	0.00180505	0.180505
311450 PALLISTER W SYNDROME;;W SYNDROME	0.00180505	0.180505
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.180505
ZLOTOGORA-OGUR SYNDROME	0.00180505	0.180505
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00180505	0.180505
DUPLICATION/INVERSION 15Q11	0.00180505	0.180505
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00180505	0.180505
HARTSFIELD SYNDROME	0.00180505	0.180505
WAARDENBURG SYNDROME TYPE 3	0.00180505	0.180505
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00180505	0.180505
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
COHEN SYNDROME	0.00180505	0.180505
OTOPALATODIGITAL SYNDROME TYPE 1	0.00180505	0.180505
THOMAS SYNDROME	0.00180505	0.180505
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001540579	0.1540579
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001540579	0.1540579
KLEEFSTRA SYNDROME 2; KLEFS2	0.001540579	0.1540579
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001540579	0.1540579
PRADER-WILLI SYNDROME; PWS	0.001540579	0.1540579
MICRO SYNDROME	0.001540579	0.1540579
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.001540579	0.1540579
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001540579	0.1540579
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001540579	0.1540579
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001540579	0.1540579
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001540579	0.1540579
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001540579	0.1540579
ALSTROM SYNDROME; ALMS	0.001540579	0.1540579
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001540579	0.1540579
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001540579	0.1540579
OCULOFACIOCARDIODENTAL SYNDROME	0.001540579	0.1540579
OCULOSKELETODENTAL SYNDROME; OCSKD	0.001540579	0.1540579
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001540579	0.1540579
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001540579	0.1540579
JOUBERT SYNDROME WITH RENAL DEFECT	0.001540579	0.1540579
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001540579	0.1540579
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001540579	0.1540579
POPOV-CHANG SYNDROME; POPCHAS	0.001540579	0.1540579
BAKER-GORDON SYNDROME; BAGOS	0.001540579	0.1540579
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.001540579	0.1540579
1Q21.1 MICRODELETION SYNDROME	0.001540579	0.1540579
COFFIN-SIRIS SYNDROME 3; CSS3	0.001540579	0.1540579
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001540579	0.1540579
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001540579	0.1540579
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001540579	0.1540579
PETTIGREW SYNDROME	0.001540579	0.1540579
COFFIN-SIRIS SYNDROME 4; CSS4	0.001540579	0.1540579
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001540579	0.1540579
PONTINE TEGMENTAL CAP DYSPLASIA	0.001540579	0.1540579
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001540579	0.1540579
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.001540579	0.1540579
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001540579	0.1540579
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.001540579	0.1540579
GERODERMA OSTEODYSPLASTICA	0.001540579	0.1540579
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001540579	0.1540579
STEEL SYNDROME; STLS	0.001540579	0.1540579
COFFIN-SIRIS SYNDROME	0.001540579	0.1540579
CODAS SYNDROME	0.001540579	0.1540579
IMMUNODEFICIENCY 23; IMD23	0.001540579	0.1540579
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001540579	0.1540579
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001540579	0.1540579
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001540579	0.1540579
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001540579	0.1540579
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001540579	0.1540579
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001540579	0.1540579
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001540579	0.1540579
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.001540579	0.1540579
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.001540579	0.1540579
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001540579	0.1540579
SLC35A2-CDG	0.001540579	0.1540579
HURLER SYNDROME	0.001540579	0.1540579
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.001540579	0.1540579
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001540579	0.1540579
FRIED SYNDROME	0.001540579	0.1540579
INCONTINENTIA PIGMENTI	0.001540579	0.1540579
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.001540579	0.1540579
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.001540579	0.1540579
COWDEN SYNDROME	0.001540579	0.1540579
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.001540579	0.1540579
MARINESCO-SJÖGREN SYNDROME	0.001540579	0.1540579
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001540579	0.1540579
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001540579	0.1540579
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001540579	0.1540579
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.001540579	0.1540579
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001540579	0.1540579
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.001540579	0.1540579
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.001540579	0.1540579
JOUBERT SYNDROME 7	0.001540579	0.1540579
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001540579	0.1540579
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001540579	0.1540579
16P13.2 MICRODELETION SYNDROME	0.001540579	0.1540579
SHWACHMAN-DIAMOND SYNDROME	0.001540579	0.1540579
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.001540579	0.1540579
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001540579	0.1540579
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001540579	0.1540579
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001540579	0.1540579
BETA-UREIDOPROPIONASE DEFICIENCY	0.001540579	0.1540579
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001540579	0.1540579
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001540579	0.1540579
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.001540579	0.1540579
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.001540579	0.1540579
CODAS SYNDROME	0.001540579	0.1540579
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.001540579	0.1540579
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001540579	0.1540579
DYSKERATOSIS CONGENITA	0.001540579	0.1540579
ROTHMUND-THOMSON SYNDROME	0.001540579	0.1540579
ALG11-CDG	0.001540579	0.1540579
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001540579	0.1540579
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001540579	0.1540579
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.001540579	0.1540579
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001540579	0.1540579
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.001540579	0.1540579
CRANIOSYNOSTOSIS 6; CRS6	0.001540579	0.1540579
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001540579	0.1540579
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001540579	0.1540579
HAREL-YOON SYNDROME; HAYOS	0.001540579	0.1540579
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.001540579	0.1540579
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001540579	0.1540579
KOOLEN-DE VRIES SYNDROME	0.001540579	0.1540579
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001540579	0.1540579
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001540579	0.1540579
DUCHENNE MUSCULAR DYSTROPHY	0.001540579	0.1540579
RIGID SPINE SYNDROME	0.001540579	0.1540579
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001540579	0.1540579
MEIER-GORLIN SYNDROME 7	0.001540579	0.1540579
MIRAGE SYNDROME; MIRAGE	0.001540579	0.1540579
HYPERMANGANESEMIA WITH DYSTONIA 2	0.001540579	0.1540579
LYMPHEDEMA, HEREDITARY, III	0.001540579	0.1540579
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001540579	0.1540579
12Q14 MICRODELETION SYNDROME	0.001540579	0.1540579
MARINESCO-SJOGREN SYNDROME; MSS	0.001540579	0.1540579
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001540579	0.1540579
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.001540579	0.1540579
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001540579	0.1540579
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001540579	0.1540579
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.001540579	0.1540579
CHARGE SYNDROME	0.001540579	0.1540579
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001540579	0.1540579
ARTERIAL TORTUOSITY SYNDROME	0.001540579	0.1540579
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.001540579	0.1540579
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001540579	0.1540579
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001540579	0.1540579
DISTAL TRISOMY 17Q	0.001540579	0.1540579
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001540579	0.1540579
MATTHEW-WOOD SYNDROME	0.0013985999999999998	0.13985999999999998
STROMME SYNDROME; STROMS	0.0013985999999999998	0.13985999999999998
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0013985999999999998	0.13985999999999998
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0013985999999999998	0.13985999999999998
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0013985999999999998	0.13985999999999998
6P22 MICRODELETION SYNDROME	0.0013985999999999998	0.13985999999999998
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0013985999999999998	0.13985999999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0013985999999999998	0.13985999999999998
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0013985999999999998	0.13985999999999998
JOUBERT SYNDROME 3; JBTS3	0.0013985999999999998	0.13985999999999998
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0013985999999999998	0.13985999999999998
CAMPOMELIC DYSPLASIA	0.0013985999999999998	0.13985999999999998
AICA-RIBOSIDURIA	0.0013985999999999998	0.13985999999999998
47,XYY SYNDROME	0.0013985999999999998	0.13985999999999998
EDINBURGH MALFORMATION SYNDROME	0.0013985999999999998	0.13985999999999998
SCHINZEL-GIEDION SYNDROME	0.0013985999999999998	0.13985999999999998
RENAL AGENESIS, BILATERAL	0.0013985999999999998	0.13985999999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0013985999999999998	0.13985999999999998
ECTODERMAL DYSPLASIA SYNDROME	0.0013985999999999998	0.13985999999999998
POLYVALVULAR HEART DISEASE SYNDROME	0.0013985999999999998	0.13985999999999998
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0013985999999999998	0.13985999999999998
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0013985999999999998	0.13985999999999998
TRANSALDOLASE DEFICIENCY	0.0013985999999999998	0.13985999999999998
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0013985999999999998	0.13985999999999998
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.0013985999999999998	0.13985999999999998
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.0013985999999999998	0.13985999999999998
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.0013985999999999998	0.13985999999999998
LETHAL KNIEST-LIKE DYSPLASIA	0.0013985999999999998	0.13985999999999998
SPONDYLO-OCULAR SYNDROME	0.0013985999999999998	0.13985999999999998
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0013985999999999998	0.13985999999999998
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.0013985999999999998	0.13985999999999998
PFEIFFER SYNDROME TYPE 3	0.0013985999999999998	0.13985999999999998
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.0013985999999999998	0.13985999999999998
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.13985999999999998
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.0013985999999999998	0.13985999999999998
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0013985999999999998	0.13985999999999998
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0013985999999999998	0.13985999999999998
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.0013985999999999998	0.13985999999999998
PELVISCAPULAR DYSPLASIA	0.0013985999999999998	0.13985999999999998
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0013985999999999998	0.13985999999999998
TEEBI-SHALTOUT SYNDROME; TBSH	0.0013985999999999998	0.13985999999999998
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.0013985999999999998	0.13985999999999998
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0013985999999999998	0.13985999999999998
LISSENCEPHALY, X-LINKED, 2	0.0013985999999999998	0.13985999999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0013985999999999998	0.13985999999999998
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.0013985999999999998	0.13985999999999998
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0013985999999999998	0.13985999999999998
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0013985999999999998	0.13985999999999998
PFEIFFER SYNDROME TYPE 1	0.0013985999999999998	0.13985999999999998
KEIPERT SYNDROME; KPTS	0.0013985999999999998	0.13985999999999998
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0013985999999999998	0.13985999999999998
BARTSOCAS-PAPAS SYNDROME; BPS	0.0013985999999999998	0.13985999999999998
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0013985999999999998	0.13985999999999998
OROFACIODIGITAL SYNDROME III	0.0013985999999999998	0.13985999999999998
TRISOMY 18-LIKE SYNDROME	0.0013985999999999998	0.13985999999999998
IMAGE SYNDROME	0.0013985999999999998	0.13985999999999998
OROFACIODIGITAL SYNDROME IV; OFD4	0.0013985999999999998	0.13985999999999998
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0013985999999999998	0.13985999999999998
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0013985999999999998	0.13985999999999998
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0013985999999999998	0.13985999999999998
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0013985999999999998	0.13985999999999998
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0013985999999999998	0.13985999999999998
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0013985999999999998	0.13985999999999998
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0013985999999999998	0.13985999999999998
MICROPHTHALMIA, SYNDROMIC 1	0.0013985999999999998	0.13985999999999998
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0013985999999999998	0.13985999999999998
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0013985999999999998	0.13985999999999998
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0013985999999999998	0.13985999999999998
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.0013985999999999998	0.13985999999999998
HYDROLETHALUS SYNDROME 1	0.0013985999999999998	0.13985999999999998
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0013985999999999998	0.13985999999999998
INIENCEPHALY	0.0013985999999999998	0.13985999999999998
JACOBSEN SYNDROME	0.0013985999999999998	0.13985999999999998
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0013985999999999998	0.13985999999999998
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0013985999999999998	0.13985999999999998
ULBRIGHT-HODES SYNDROME	0.0013985999999999998	0.13985999999999998
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0013985999999999998	0.13985999999999998
OTOFACIOCERVICAL SYNDROME 2	0.0013985999999999998	0.13985999999999998
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0013985999999999998	0.13985999999999998
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0013985999999999998	0.13985999999999998
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.0013985999999999998	0.13985999999999998
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.0013985999999999998	0.13985999999999998
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0013985999999999998	0.13985999999999998
HENNEKAM SYNDROME	0.0013985999999999998	0.13985999999999998
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.0013985999999999998	0.13985999999999998
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0013985999999999998	0.13985999999999998
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0013985999999999998	0.13985999999999998
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.0013985999999999998	0.13985999999999998
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0013985999999999998	0.13985999999999998
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.0013985999999999998	0.13985999999999998
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0013985999999999998	0.13985999999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0013985999999999998	0.13985999999999998
VERVERI-BRADY SYNDROME; VERBRAS	0.0013985999999999998	0.13985999999999998
WIEDEMANN-STEINER SYNDROME	0.0013985999999999998	0.13985999999999998
KYPHOMELIC DYSPLASIA	0.0013985999999999998	0.13985999999999998
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0013985999999999998	0.13985999999999998
PYKNOACHONDROGENESIS	0.0013985999999999998	0.13985999999999998
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0013985999999999998	0.13985999999999998
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0013985999999999998	0.13985999999999998
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.0013985999999999998	0.13985999999999998
MEIER-GORLIN SYNDROME 8; MGORS8	0.0013985999999999998	0.13985999999999998
SIFRIM-HITZ-WEISS SYNDROME	0.0013985999999999998	0.13985999999999998
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0013985999999999998	0.13985999999999998
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0013985999999999998	0.13985999999999998
OROFACIAL CLEFT 15	0.0013985999999999998	0.13985999999999998
OROFACIODIGITAL SYNDROME TYPE 3	0.0013985999999999998	0.13985999999999998
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.0013985999999999998	0.13985999999999998
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0013985999999999998	0.13985999999999998
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0013985999999999998	0.13985999999999998
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0013985999999999998	0.13985999999999998
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0013985999999999998	0.13985999999999998
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0013985999999999998	0.13985999999999998
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0013985999999999998	0.13985999999999998
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0013985999999999998	0.13985999999999998
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0013985999999999998	0.13985999999999998
FGFR2-RELATED BENT BONE DYSPLASIA	0.0013985999999999998	0.13985999999999998
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0013985999999999998	0.13985999999999998
BENT BONE DYSPLASIA SYNDROME; BBDS	0.0013985999999999998	0.13985999999999998
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.0013985999999999998	0.13985999999999998
MEIER-GORLIN SYNDROME 1; MGORS1	0.0013985999999999998	0.13985999999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0013985999999999998	0.13985999999999998
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.0013985999999999998	0.13985999999999998
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0013985999999999998	0.13985999999999998
MONOSOMY 13Q14	0.0013985999999999998	0.13985999999999998
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0013985999999999998	0.13985999999999998
HAMAMY SYNDROME; HMMS	0.0013985999999999998	0.13985999999999998
PRIMARY PULMONARY HYPOPLASIA	0.0013985999999999998	0.13985999999999998
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0013985999999999998	0.13985999999999998
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0013985999999999998	0.13985999999999998
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0013985999999999998	0.13985999999999998
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0013985999999999998	0.13985999999999998
GLUTAMINE DEFICIENCY, CONGENITAL	0.0013985999999999998	0.13985999999999998
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0013985999999999998	0.13985999999999998
ATELOSTEOGENESIS TYPE II	0.0013985999999999998	0.13985999999999998
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0013985999999999998	0.13985999999999998
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.0013985999999999998	0.13985999999999998
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0013985999999999998	0.13985999999999998
ACROCARDIOFACIAL SYNDROME	0.0013985999999999998	0.13985999999999998
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.0013985999999999998	0.13985999999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0013985999999999998	0.13985999999999998
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.13985999999999998
FRYNS SYNDROME; FRNS	0.0013985999999999998	0.13985999999999998
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0013985999999999998	0.13985999999999998
TETRAAMELIA SYNDROME 2; TETAMS2	0.0013985999999999998	0.13985999999999998
FIBROCHONDROGENESIS 1; FBCG1	0.0013985999999999998	0.13985999999999998
SECKEL SYNDROME 4	0.0013985999999999998	0.13985999999999998
SLC39A8-CDG	0.0013985999999999998	0.13985999999999998
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0013985999999999998	0.13985999999999998
GAPO SYNDROME	0.0013985999999999998	0.13985999999999998
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.13985999999999998
FRONTONASAL DYSPLASIA 1; FND1	0.0013985999999999998	0.13985999999999998
16P12.1P12.3 TRIPLICATION SYNDROME	0.0013985999999999998	0.13985999999999998
BARBER-SAY SYNDROME; BBRSAY	0.0013985999999999998	0.13985999999999998
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.0013985999999999998	0.13985999999999998
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0013985999999999998	0.13985999999999998
SPRENGEL DEFORMITY	0.000995025	0.09950250000000001
ODONTOCHONDRODYSPLASIA; ODCD	0.000995025	0.09950250000000001
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.000995025	0.09950250000000001
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.000995025	0.09950250000000001
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.000995025	0.09950250000000001
DIPHALLIA	0.000995025	0.09950250000000001
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.000995025	0.09950250000000001
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.000995025	0.09950250000000001
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000995025	0.09950250000000001
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.000995025	0.09950250000000001
FRYNS-SMEETS-THIRY SYNDROME	0.000995025	0.09950250000000001
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000995025	0.09950250000000001
HALL-RIGGS SYNDROME	0.000995025	0.09950250000000001
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.000995025	0.09950250000000001
FLYNN-AIRD SYNDROME	0.000995025	0.09950250000000001
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.000995025	0.09950250000000001
SYRINGOMYELIA, ISOLATED	0.000995025	0.09950250000000001
SHPRINTZEN OMPHALOCELE SYNDROME	0.000995025	0.09950250000000001
ENG-STROM SYNDROME	0.000995025	0.09950250000000001
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.000995025	0.09950250000000001
ISOLATED HEMIHYPERPLASIA	0.000995025	0.09950250000000001
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000995025	0.09950250000000001
HARROD SYNDROME	0.000995025	0.09950250000000001
HIP DYSPLASIA, BEUKES TYPE	0.000995025	0.09950250000000001
HENNEKAM-BEEMER SYNDROME	0.000995025	0.09950250000000001
CARTILAGE-HAIR HYPOPLASIA; CHH	0.000995025	0.09950250000000001
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.000995025	0.09950250000000001
MUCOPOLYSACCHARIDOSIS TYPE 4	0.000995025	0.09950250000000001
ALLAN-HERNDON-DUDLEY SYNDROME	0.000995025	0.09950250000000001
CLEIDOCRANIAL DYSPLASIA; CCD	0.000995025	0.09950250000000001
LAING EARLY-ONSET DISTAL MYOPATHY	0.000995025	0.09950250000000001
CENTRONUCLEAR MYOPATHY	0.000995025	0.09950250000000001
X-LINKED CENTRONUCLEAR MYOPATHY	0.000995025	0.09950250000000001
MULTIMINICORE MYOPATHY	0.000995025	0.09950250000000001
LOEYS-DIETZ SYNDROME	0.000995025	0.09950250000000001
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.000995025	0.09950250000000001
CHIARI MALFORMATION TYPE I	0.000995025	0.09950250000000001
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000995025	0.09950250000000001
DIASTROPHIC DWARFISM	0.000995025	0.09950250000000001
ACROCAPITOFEMORAL DYSPLASIA	0.000995025	0.09950250000000001
NEUROFIBROMATOSIS TYPE 1	0.000995025	0.09950250000000001
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.000995025	0.09950250000000001
GIANT AXONAL NEUROPATHY	0.000995025	0.09950250000000001
NEVUS COMEDONICUS SYNDROME	0.000995025	0.09950250000000001
BECKER NEVUS SYNDROME	0.000995025	0.09950250000000001
NORRIE DISEASE	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA	0.000995025	0.09950250000000001
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.000995025	0.09950250000000001
PRADER-WILLI SYNDROME	0.000995025	0.09950250000000001
MUCOPOLYSACCHARIDOSIS TYPE 7	0.000995025	0.09950250000000001
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000995025	0.09950250000000001
PSEUDOXANTHOMA ELASTICUM	0.000995025	0.09950250000000001
MICROPHTHALMIA, LENZ TYPE	0.000995025	0.09950250000000001
KNIEST DYSPLASIA	0.000995025	0.09950250000000001
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.000995025	0.09950250000000001
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.000995025	0.09950250000000001
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.000995025	0.09950250000000001
DYSTONIA, DOPA-RESPONSIVE; DRD	0.000995025	0.09950250000000001
TERMINAL TRANSVERSE LIMB DEFECT	0.000995025	0.09950250000000001
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.000995025	0.09950250000000001
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.000995025	0.09950250000000001
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.000995025	0.09950250000000001
LERI-WEILL DYSCHONDROSTEOSIS	0.000995025	0.09950250000000001
LARSEN SYNDROME	0.000995025	0.09950250000000001
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.000995025	0.09950250000000001
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.000995025	0.09950250000000001
CRANIOLENTICULOSUTURAL DYSPLASIA	0.000995025	0.09950250000000001
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.000995025	0.09950250000000001
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.000995025	0.09950250000000001
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS 5	0.000995025	0.09950250000000001
GNATHODIAPHYSEAL DYSPLASIA	0.000995025	0.09950250000000001
MARSHALL-SMITH SYNDROME	0.000995025	0.09950250000000001
PSEUDOACHONDROPLASIA	0.000995025	0.09950250000000001
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA TYPE 42	0.000995025	0.09950250000000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.000995025	0.09950250000000001
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.000995025	0.09950250000000001
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.000995025	0.09950250000000001
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.000995025	0.09950250000000001
ULNAR HEMIMELIA	0.000995025	0.09950250000000001
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.000995025	0.09950250000000001
SPONASTRIME DYSPLASIA	0.000995025	0.09950250000000001
BRACHYDACTYLY TYPE A1	0.000995025	0.09950250000000001
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.000995025	0.09950250000000001
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.000995025	0.09950250000000001
FRIEDREICH ATAXIA	0.000995025	0.09950250000000001
ATAXIA WITH VITAMIN E DEFICIENCY	0.000995025	0.09950250000000001
MOSAIC TRISOMY 8	0.000995025	0.09950250000000001
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000995025	0.09950250000000001
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.000995025	0.09950250000000001
PERIVENTRICULAR NODULAR HETEROTOPIA	0.000995025	0.09950250000000001
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA TYPE 7	0.000995025	0.09950250000000001
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.000995025	0.09950250000000001
49,XYYYY SYNDROME	0.000995025	0.09950250000000001
BRACHYOLMIA, MAROTEAUX TYPE	0.000995025	0.09950250000000001
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.000995025	0.09950250000000001
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.000995025	0.09950250000000001
ASPARTYLGLUCOSAMINURIA	0.000995025	0.09950250000000001
RETT SYNDROME	0.000995025	0.09950250000000001
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000995025	0.09950250000000001
COLE-CARPENTER SYNDROME 1; CLCRP1	0.000995025	0.09950250000000001
SCHWARTZ-JAMPEL SYNDROME	0.000995025	0.09950250000000001
SIALIDOSIS TYPE 1	0.000995025	0.09950250000000001
BASAL CELL NEVUS SYNDROME	0.000995025	0.09950250000000001
SJÖGREN-LARSSON SYNDROME	0.000995025	0.09950250000000001
ISOLATED SPINA BIFIDA	0.000995025	0.09950250000000001
STICKLER SYNDROME	0.000995025	0.09950250000000001
STICKLER SYNDROME, TYPE I	0.000995025	0.09950250000000001
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.000995025	0.09950250000000001
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.000995025	0.09950250000000001
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.09950250000000001
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.000995025	0.09950250000000001
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.000995025	0.09950250000000001
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000995025	0.09950250000000001
WAGR SYNDROME	0.000995025	0.09950250000000001
WAARDENBURG SYNDROME TYPE 1	0.000995025	0.09950250000000001
BRITTLE CORNEA SYNDROME	0.000995025	0.09950250000000001
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.000995025	0.09950250000000001
AASE-SMITH SYNDROME	0.000995025	0.09950250000000001
CAMURATI-ENGELMANN DISEASE	0.000995025	0.09950250000000001
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.000995025	0.09950250000000001
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000995025	0.09950250000000001
16Q24.3 MICRODELETION SYNDROME	0.000995025	0.09950250000000001
3M SYNDROME	0.000995025	0.09950250000000001
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.000995025	0.09950250000000001
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000995025	0.09950250000000001
METATROPIC DYSPLASIA	0.000995025	0.09950250000000001
OSTEOGLOSPHONIC DYSPLASIA	0.000995025	0.09950250000000001
ARNOLD-CHIARI MALFORMATION TYPE I	0.000995025	0.09950250000000001
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.000995025	0.09950250000000001
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE IV	0.000995025	0.09950250000000001
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.000995025	0.09950250000000001
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000995025	0.09950250000000001
BRUCK SYNDROME	0.000995025	0.09950250000000001
OSTEOMESOPYKNOSIS	0.000995025	0.09950250000000001
PACHYDERMOPERIOSTOSIS	0.000995025	0.09950250000000001
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.000995025	0.09950250000000001
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.09950250000000001
LERI PLEONOSTEOSIS	0.000995025	0.09950250000000001
POLAND SYNDROME	0.000995025	0.09950250000000001
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.000995025	0.09950250000000001
OROFACIODIGITAL SYNDROME TYPE 5	0.000995025	0.09950250000000001
OROFACIODIGITAL SYNDROME V; OFD5	0.000995025	0.09950250000000001
LINEAR VERRUCOUS NEVUS SYNDROME	0.000995025	0.09950250000000001
ACRODYSPLASIA SCOLIOSIS	0.000995025	0.09950250000000001
POSTERIOR COLUMN ATAXIA	0.000995025	0.09950250000000001
IVIC SYNDROME	0.000995025	0.09950250000000001
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.000995025	0.09950250000000001
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.000995025	0.09950250000000001
JUBERG-HAYWARD SYNDROME	0.000995025	0.09950250000000001
ISOLATED KLIPPEL-FEIL SYNDROME	0.000995025	0.09950250000000001
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000995025	0.09950250000000001
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000995025	0.09950250000000001
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.000995025	0.09950250000000001
PSEUDOACHONDROPLASIA	0.000995025	0.09950250000000001
MCDONOUGH SYNDROME	0.000995025	0.09950250000000001
MELNICK-NEEDLES SYNDROME	0.000995025	0.09950250000000001
ACROGERIA	0.000995025	0.09950250000000001
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.000995025	0.09950250000000001
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000995025	0.09950250000000001
GANGLIOCYTOMA	0.000995025	0.09950250000000001
PURE MITOCHONDRIAL MYOPATHY	0.000995025	0.09950250000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.000995025	0.09950250000000001
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.000995025	0.09950250000000001
OLIVER SYNDROME	0.000995025	0.09950250000000001
NEUROFIBROMATOSIS, TYPE I	0.000995025	0.09950250000000001
HYPOPHOSPHATEMIC RICKETS	0.000995025	0.09950250000000001
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.000995025	0.09950250000000001
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.000995025	0.09950250000000001
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.000995025	0.09950250000000001
GM1 GANGLIOSIDOSIS	0.000995025	0.09950250000000001
MADELUNG DEFORMITY	0.000995025	0.09950250000000001
MARFANOID HYPERMOBILITY SYNDROME	0.000995025	0.09950250000000001
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.000995025	0.09950250000000001
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.000995025	0.09950250000000001
IVIC SYNDROME	0.000995025	0.09950250000000001
GOLDENHAR SYNDROME	0.000995025	0.09950250000000001
GORDON SYNDROME	0.000995025	0.09950250000000001
GORLIN SYNDROME	0.000995025	0.09950250000000001
ATYPICAL JUVENILE PARKINSONISM	0.000995025	0.09950250000000001
FRONTORHINY	0.000995025	0.09950250000000001
HOLT-ORAM SYNDROME	0.000995025	0.09950250000000001
CLASSIC HOMOCYSTINURIA	0.000995025	0.09950250000000001
OCULOAURICULOFRONTONASAL SYNDROME	0.000995025	0.09950250000000001
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.000995025	0.09950250000000001
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.000995025	0.09950250000000001
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.000995025	0.09950250000000001
HYPOCHONDROPLASIA	0.000995025	0.09950250000000001
KEPPEN-LUBINSKY SYNDROME	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.000995025	0.09950250000000001
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.000995025	0.09950250000000001
NEMALINE MYOPATHY 3; NEM3	0.000995025	0.09950250000000001
WEISMANN-NETTER SYNDROME	0.000995025	0.09950250000000001
CAUDAL REGRESSION SEQUENCE	0.000995025	0.09950250000000001
NAIL-PATELLA SYNDROME	0.000995025	0.09950250000000001
MYOPATHY, DISTAL, 1; MPD1	0.000995025	0.09950250000000001
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.000995025	0.09950250000000001
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.000995025	0.09950250000000001
SHOX-RELATED SHORT STATURE	0.000995025	0.09950250000000001
SILLENCE SYNDROME	0.000995025	0.09950250000000001
SPONDYLOCAMPTODACTYLY SYNDROME	0.000995025	0.09950250000000001
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.000995025	0.09950250000000001
STÜVE-WIEDEMANN SYNDROME	0.000995025	0.09950250000000001
MULTIPLE OSTEOCHONDROMAS	0.000995025	0.09950250000000001
FOUNTAIN SYNDROME	0.000995025	0.09950250000000001
METATROPIC DYSPLASIA	0.000995025	0.09950250000000001
CLASSIC MULTIMINICORE MYOPATHY	0.000995025	0.09950250000000001
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.000995025	0.09950250000000001
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.000995025	0.09950250000000001
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.000995025	0.09950250000000001
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.000995025	0.09950250000000001
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.000995025	0.09950250000000001
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000995025	0.09950250000000001
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.000995025	0.09950250000000001
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.000995025	0.09950250000000001
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.000995025	0.09950250000000001
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000995025	0.09950250000000001
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.000995025	0.09950250000000001
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.000995025	0.09950250000000001
231970 GLUTEAL MUSCLES, ABSENCE OF	0.000995025	0.09950250000000001
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.000995025	0.09950250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.000995025	0.09950250000000001
GAPO SYNDROME; GAPOS	0.000995025	0.09950250000000001
ASPARTYLGLUCOSAMINURIA; AGU	0.000995025	0.09950250000000001
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.000995025	0.09950250000000001
AICARDI SYNDROME; AIC	0.000995025	0.09950250000000001
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.000995025	0.09950250000000001
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.000995025	0.09950250000000001
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.000995025	0.09950250000000001
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.000995025	0.09950250000000001
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.000995025	0.09950250000000001
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.000995025	0.09950250000000001
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.000995025	0.09950250000000001
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000995025	0.09950250000000001
LEBER OPTIC ATROPHY AND DYSTONIA	0.000995025	0.09950250000000001
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.000995025	0.09950250000000001
SPONDYLOCAMPTODACTYLY	0.000995025	0.09950250000000001
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.000995025	0.09950250000000001
HUNTER-MACDONALD SYNDROME	0.000995025	0.09950250000000001
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000995025	0.09950250000000001
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000995025	0.09950250000000001
MENTAL RETARDATION, X-LINKED 102	0.000995025	0.09950250000000001
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.000995025	0.09950250000000001
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.000995025	0.09950250000000001
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.000995025	0.09950250000000001
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.000995025	0.09950250000000001
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.000995025	0.09950250000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.000995025	0.09950250000000001
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000995025	0.09950250000000001
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.000995025	0.09950250000000001
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000995025	0.09950250000000001
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.000995025	0.09950250000000001
WEILL-MARCHESANI SYNDROME 1; WMS1	0.000995025	0.09950250000000001
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.000995025	0.09950250000000001
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.000995025	0.09950250000000001
VAN MALDERGEM SYNDROME 2; VMLDS2	0.000995025	0.09950250000000001
FACIOCARDIORENAL SYNDROME	0.000995025	0.09950250000000001
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.000995025	0.09950250000000001
COFFIN-SIRIS SYNDROME 8; CSS8	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE X	0.000995025	0.09950250000000001
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.000995025	0.09950250000000001
MENTAL RETARDATION, X-LINKED 82	0.000995025	0.09950250000000001
ALLAN-HERNDON-DUDLEY SYNDROME	0.000995025	0.09950250000000001
FRAGILE X MENTAL RETARDATION SYNDROME	0.000995025	0.09950250000000001
LOEYS-DIETZ SYNDROME 3; LDS3	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.000995025	0.09950250000000001
BRITTLE CORNEA SYNDROME	0.000995025	0.09950250000000001
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.000995025	0.09950250000000001
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000995025	0.09950250000000001
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.000995025	0.09950250000000001
SALIH MYOPATHY; SALMY	0.000995025	0.09950250000000001
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000995025	0.09950250000000001
NEMALINE MYOPATHY 1; NEM1	0.000995025	0.09950250000000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.000995025	0.09950250000000001
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.000995025	0.09950250000000001
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.000995025	0.09950250000000001
HEMIHYPERPLASIA, ISOLATED	0.000995025	0.09950250000000001
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.000995025	0.09950250000000001
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.000995025	0.09950250000000001
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.000995025	0.09950250000000001
MYOCLONIC-ATONIC EPILEPSY	0.000995025	0.09950250000000001
HURLER-SCHEIE SYNDROME	0.000995025	0.09950250000000001
CZECH DYSPLASIA, METATARSAL TYPE	0.000995025	0.09950250000000001
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.000995025	0.09950250000000001
DUANE-RADIAL RAY SYNDROME; DRRS	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.000995025	0.09950250000000001
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.000995025	0.09950250000000001
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.000995025	0.09950250000000001
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.000995025	0.09950250000000001
CRANIOLENTICULOSUTURAL DYSPLASIA	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.000995025	0.09950250000000001
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.000995025	0.09950250000000001
MYOPATHY, SCAPULOHUMEROPERONEAL	0.000995025	0.09950250000000001
WEILL-MARCHESANI SYNDROME 2; WMS2	0.000995025	0.09950250000000001
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.000995025	0.09950250000000001
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.000995025	0.09950250000000001
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000995025	0.09950250000000001
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.000995025	0.09950250000000001
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.000995025	0.09950250000000001
VAN MALDERGEM SYNDROME 1; VMLDS1	0.000995025	0.09950250000000001
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.000995025	0.09950250000000001
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.000995025	0.09950250000000001
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.000995025	0.09950250000000001
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.000995025	0.09950250000000001
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.000995025	0.09950250000000001
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.000995025	0.09950250000000001
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000995025	0.09950250000000001
RIGID SPINE MUSCULAR DYSTROPHY 1	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.000995025	0.09950250000000001
XFE PROGEROID SYNDROME; XFEPS	0.000995025	0.09950250000000001
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.000995025	0.09950250000000001
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.000995025	0.09950250000000001
TENORIO SYNDROME; TNORS	0.000995025	0.09950250000000001
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.000995025	0.09950250000000001
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.000995025	0.09950250000000001
TOWNES-BROCKS SYNDROME 2; TBS2	0.000995025	0.09950250000000001
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.000995025	0.09950250000000001
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.000995025	0.09950250000000001
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.000995025	0.09950250000000001
PENTALOGY OF CANTRELL	0.000995025	0.09950250000000001
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.000995025	0.09950250000000001
TIBIAL TORSION, BILATERAL MEDIAL	0.000995025	0.09950250000000001
CAMURATI-ENGELMANN DISEASE	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE IX	0.000995025	0.09950250000000001
DESBUQUOIS DYSPLASIA 1	0.000995025	0.09950250000000001
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.000995025	0.09950250000000001
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.000995025	0.09950250000000001
CAFFEY DISEASE	0.000995025	0.09950250000000001
ODONTOCHONDRODYSPLASIA	0.000995025	0.09950250000000001
DIASTEMATOMYELIA	0.000995025	0.09950250000000001
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000995025	0.09950250000000001
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.000995025	0.09950250000000001
TYPICAL NEMALINE MYOPATHY	0.000995025	0.09950250000000001
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.000995025	0.09950250000000001
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000995025	0.09950250000000001
BALLER-GEROLD SYNDROME	0.000995025	0.09950250000000001
ESOPHAGEAL ATRESIA	0.000995025	0.09950250000000001
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.000995025	0.09950250000000001
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.09950250000000001
TRISOMY 4P	0.000995025	0.09950250000000001
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.000995025	0.09950250000000001
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 13	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.000995025	0.09950250000000001
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000995025	0.09950250000000001
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.000995025	0.09950250000000001
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.09950250000000001
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.000995025	0.09950250000000001
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.000995025	0.09950250000000001
COOPER-JABS SYNDROME	0.000995025	0.09950250000000001
ATELOSTEOGENESIS, TYPE II	0.000995025	0.09950250000000001
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000995025	0.09950250000000001
CRISPONI SYNDROME	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000995025	0.09950250000000001
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.09950250000000001
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000995025	0.09950250000000001
SYMBRACHYDACTYLY OF HANDS AND FEET	0.000995025	0.09950250000000001
DESBUQUOIS SYNDROME	0.000995025	0.09950250000000001
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.000995025	0.09950250000000001
MUCOLIPIDOSIS III GAMMA	0.000995025	0.09950250000000001
MAFFUCCI SYNDROME	0.000995025	0.09950250000000001
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.000995025	0.09950250000000001
MUCOLIPIDOSIS III ALPHA/BETA	0.000995025	0.09950250000000001
CATEL-MANZKE SYNDROME	0.000995025	0.09950250000000001
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000995025	0.09950250000000001
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.000995025	0.09950250000000001
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.000995025	0.09950250000000001
OPSISMODYSPLASIA; OPSMD	0.000995025	0.09950250000000001
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.000995025	0.09950250000000001
TRISOMY 5P	0.000995025	0.09950250000000001
MAXILLONASAL DYSPLASIA	0.000995025	0.09950250000000001
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.000995025	0.09950250000000001
COWDEN SYNDROME 6; CWS6	0.000995025	0.09950250000000001
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000995025	0.09950250000000001
AREDYLD SYNDROME	0.000995025	0.09950250000000001
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.000995025	0.09950250000000001
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.000995025	0.09950250000000001
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000995025	0.09950250000000001
45,X/46,XY MIXED GONADAL DYSGENESIS	0.000995025	0.09950250000000001
CARTILAGE-HAIR HYPOPLASIA	0.000995025	0.09950250000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.09950250000000001
THORACOLARYNGOPELVIC DYSPLASIA	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA TYPE 25	0.000995025	0.09950250000000001
COWDEN SYNDROME 5; CWS5	0.000995025	0.09950250000000001
DYSOSTOSIS, STANESCU TYPE	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.000995025	0.09950250000000001
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.000995025	0.09950250000000001
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.000995025	0.09950250000000001
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000995025	0.09950250000000001
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000995025	0.09950250000000001
RAMON SYNDROME	0.000995025	0.09950250000000001
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.000995025	0.09950250000000001
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.000995025	0.09950250000000001
SHELDON-HALL SYNDROME	0.000995025	0.09950250000000001
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.000995025	0.09950250000000001
PYCNODYSOSTOSIS	0.000995025	0.09950250000000001
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.000995025	0.09950250000000001
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.09950250000000001
FAMILIAL DYSAUTONOMIA	0.000995025	0.09950250000000001
PYLE DISEASE; PYL	0.000995025	0.09950250000000001
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.000995025	0.09950250000000001
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.000995025	0.09950250000000001
KUSKOKWIM SYNDROME	0.000995025	0.09950250000000001
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.0545554
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.0545554
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.0545554
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.0545554
JOUBERT SYNDROME 6	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.0545554
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000545554	0.0545554
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.0545554
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.0545554
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.0545554
HOLOPROSENCEPHALY 7	0.000545554	0.0545554
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.0545554
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.0545554
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.0545554
MEDULLOBLASTOMA	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.0545554
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.0545554
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.0545554
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.0545554
PHACE SYNDROME	0.000545554	0.0545554
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.0545554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.0545554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.0545554
WYBURN-MASON SYNDROME	0.000545554	0.0545554
ALSTRÖM SYNDROME	0.000545554	0.0545554
NARP SYNDROME	0.000545554	0.0545554
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.0545554
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.0545554
COG2-CDG	0.000545554	0.0545554
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.0545554
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.0545554
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.000545554	0.0545554
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.0545554
SCHINDLER DISEASE, TYPE I	0.000545554	0.0545554
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.0545554
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.0545554
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.0545554
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.0545554
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000545554	0.0545554
NETHERTON SYNDROME	0.000545554	0.0545554
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.0545554
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.0545554
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.0545554
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.0545554
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.0545554
ATELOSTEOGENESIS TYPE III	0.000545554	0.0545554
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.0545554
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.0545554
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.0545554
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.0545554
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.0545554
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.0545554
CRANIOPHARYNGIOMA	0.000545554	0.0545554
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.0545554
HARTNUP DISORDER	0.000545554	0.0545554
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.0545554
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.0545554
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.0545554
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.0545554
LEBER CONGENITAL AMAUROSIS	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.0545554
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.0545554
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.0545554
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.0545554
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.0545554
MONOSOMY 22Q13.3	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.0545554
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.0545554
KRABBE DISEASE	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.0545554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.0545554
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
TRANSKETOLASE DEFICIENCY	0.000545554	0.0545554
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.0545554
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.0545554
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.0545554
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.0545554
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000545554	0.0545554
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.0545554
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.0545554
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.0545554
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.0545554
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.0545554
LISSENCEPHALY 4	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.0545554
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.0545554
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000545554	0.0545554
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000545554	0.0545554
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.0545554
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.0545554
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.0545554
HOLOPROSENCEPHALY 11	0.000545554	0.0545554
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.0545554
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.0545554
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.0545554
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.0545554
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.0545554
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.0545554
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.0545554
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.0545554
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.0545554
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000545554	0.0545554
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.0545554
MAPLE SYRUP URINE DISEASE	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.0545554
XQ25 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.0545554
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.0545554
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000545554	0.0545554
JOUBERT SYNDROME 15	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000545554	0.0545554
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.0545554
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.0545554
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.0545554
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.0545554
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.0545554
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.0545554
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.0545554
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.0545554
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.0545554
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.0545554
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.0545554
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.0545554
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.0545554
JOUBERT SYNDROME 8	0.000545554	0.0545554
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000545554	0.0545554
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000545554	0.0545554
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000545554	0.0545554
GAUCHER DISEASE, TYPE II	0.000545554	0.0545554
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.0545554
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.0545554
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.0545554
BARATELA-SCOTT SYNDROME	0.000545554	0.0545554
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.0545554
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.0545554
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000545554	0.0545554
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000545554	0.0545554
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.0545554
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.0545554
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.0545554
WAARDENBURG-SHAH SYNDROME	0.000545554	0.0545554
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.0545554
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.0545554
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.0545554
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.0545554
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.0545554
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.0545554
LANDAU-KLEFFNER SYNDROME	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.0545554
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.0545554
TETRASOMY X	0.000545554	0.0545554
ARGININEMIA	0.000545554	0.0545554
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.0545554
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.0545554
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.0545554
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.0545554
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.0545554
XQ25 DUPLICATION SYNDROME	0.000545554	0.0545554
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.0545554
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.0545554
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.0545554
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.0545554
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.000545554	0.0545554
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.0545554
ELEJALDE DISEASE	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.0545554
8P23.1 DUPLICATION SYNDROME	0.000545554	0.0545554
NETHERTON SYNDROME; NETH	0.000545554	0.0545554
LEIGH SYNDROME; LS	0.000545554	0.0545554
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.0545554
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000545554	0.0545554
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.0545554
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.0545554
MUCOLIPIDOSIS IV; ML4	0.000545554	0.0545554
48,XYYY SYNDROME	0.000545554	0.0545554
SULFOCYSTEINURIA	0.000545554	0.0545554
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.0545554
JAWAD SYNDROME	0.000545554	0.0545554
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.0545554
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.0545554
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.0545554
LIG4 SYNDROME	0.000545554	0.0545554
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.0545554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.0545554
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.0545554
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000545554	0.0545554
POTOCKI-SHAFFER SYNDROME	0.000545554	0.0545554
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.0545554
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.0545554
NAVAJO NEUROHEPATOPATHY	0.000545554	0.0545554
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.0545554
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
REVESZ SYNDROME	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.0545554
DISTAL MONOSOMY 19P13.3	0.000545554	0.0545554
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.000545554	0.0545554
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.0545554
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.0545554
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.0545554
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.0545554
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.0545554
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.0545554
PELLAGRA-LIKE SYNDROME	0.000545554	0.0545554
PEHO SYNDROME; PEHO	0.000545554	0.0545554
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.0545554
ADAMS-OLIVER SYNDROME 1; AOS1	0.000545554	0.0545554
OROTIC ACIDURIA	0.000545554	0.0545554
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.0545554
ZEBRA BODY MYOPATHY	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.0545554
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.0545554
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.0545554
HYDROXYKYNURENINURIA	0.000545554	0.0545554
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.0545554
FUMARASE DEFICIENCY; FMRD	0.000545554	0.0545554
LIG4 SYNDROME	0.000545554	0.0545554
PHACE ASSOCIATION	0.000545554	0.0545554
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.0545554
HYPERPROLINEMIA, TYPE I	0.000545554	0.0545554
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.0545554
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.0545554
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.0545554
INFANTILE REFSUM DISEASE	0.000545554	0.0545554
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.0545554
BIOTINIDASE DEFICIENCY	0.000545554	0.0545554
CLASSIC PHENYLKETONURIA	0.000545554	0.0545554
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.0545554
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.0545554
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.0545554
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.0545554
PMM2-CDG	0.000545554	0.0545554
ALG6-CDG	0.000545554	0.0545554
ALG3-CDG	0.000545554	0.0545554
ALG1-CDG	0.000545554	0.0545554
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.0545554
RABSON-MENDENHALL SYNDROME	0.000545554	0.0545554
SIALIDOSIS TYPE 2	0.000545554	0.0545554
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.0545554
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.0545554
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.0545554
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.0545554
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.0545554
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.0545554
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.0545554
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.0545554
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
LISSENCEPHALY 1; LIS1	0.000545554	0.0545554
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.0545554
HYDROXYKYNURENINURIA	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.0545554
WOLMAN DISEASE	0.000545554	0.0545554
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.0545554
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.0545554
HURLER SYNDROME	0.000545554	0.0545554
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000545554	0.0545554
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.0545554
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.0545554
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.0545554
BAND HETEROTOPIA; BH	0.000545554	0.0545554
OCULOECTODERMAL SYNDROME; OES	0.000545554	0.0545554
LOWRY-MACLEAN SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.0545554
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.0545554
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.0545554
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.0545554
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.0545554
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.0545554
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.0545554
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.0545554
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.0545554
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.0545554
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.0545554
KETOADIPICACIDURIA	0.000545554	0.0545554
DPAGT1-CDG	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000545554	0.0545554
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.0545554
WAISMAN SYNDROME; WSMN	0.000545554	0.0545554
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.0545554
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.0545554
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.0545554
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.0545554
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.0545554
SALLA DISEASE	0.000545554	0.0545554
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.0545554
GRISCELLI SYNDROME TYPE 1	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.0545554
SCHIZENCEPHALY	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.0545554
CDAGS SYNDROME	0.000545554	0.0545554
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.0545554
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.0545554
CURRY-JONES SYNDROME	0.000545554	0.0545554
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000545554	0.0545554
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.0545554
TAY-SACHS DISEASE	0.000545554	0.0545554
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.0545554
ARIMA SYNDROME	0.000545554	0.0545554
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000545554	0.0545554
TIMOTHY SYNDROME; TS	0.000545554	0.0545554
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.0545554
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.0545554
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.0545554
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.0545554
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.0545554
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.0545554
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000545554	0.0545554
XP21 MICRODELETION SYNDROME	0.000545554	0.0545554
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.0545554
17Q12 MICRODELETION SYNDROME	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.0545554
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000545554	0.0545554
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.0545554
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.0545554
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.0545554
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.0545554
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.0545554
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.0545554
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.0545554
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.0545554
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000545554	0.0545554
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.0545554
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.0545554
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.0545554
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.0545554
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.0545554
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.0545554
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000545554	0.0545554
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
MIETENS SYNDROME	0.000545554	0.0545554
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.0545554
AUSTRALIA ANTIGEN	0.000545554	0.0545554
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000545554	0.0545554
N SYNDROME	0.000545554	0.0545554
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.0545554
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.0545554
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.0545554
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.0545554
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.0545554
MECKEL SYNDROME 13; MKS13	0.000545554	0.0545554
RAHMAN SYNDROME	0.000545554	0.0545554
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.0545554
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.0545554
OTOFACIOCERVICAL SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.0545554
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000545554	0.0545554
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.0545554
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.0545554
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.0545554
OPTIC ATROPHY 11; OPA11	0.000545554	0.0545554
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.0545554
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.0545554
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.0545554
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.0545554
PEHO SYNDROME	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.0545554
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.0545554
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.0545554
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.0545554
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.0545554
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.0545554
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.0545554
PELGER-HUET ANOMALY; PHA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000545554	0.0545554
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.0545554
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.0545554
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000545554	0.0545554
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.0545554
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.0545554
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.0545554
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 6	0.000545554	0.0545554
L1 SYNDROME	0.000545554	0.0545554
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.0545554
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.0545554
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.0545554
RIDDLE SYNDROME	0.000545554	0.0545554
SEPTOOPTIC DYSPLASIA	0.000545554	0.0545554
RING CHROMOSOME 22 SYNDROME	0.000545554	0.0545554
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.0545554
XQ21 MICRODELETION SYNDROME	0.000545554	0.0545554
HARTNUP DISEASE	0.000545554	0.0545554
CANAVAN DISEASE	0.000545554	0.0545554
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.0545554
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.0545554
AURICULOCONDYLAR SYNDROME	0.000545554	0.0545554
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.0545554
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.0545554
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000545554	0.0545554
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.0545554
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
HYDRANENCEPHALY	0.000545554	0.0545554
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.0545554
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.0545554
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.0545554
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.0545554
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.0545554
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.0545554
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.0545554
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.0545554
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.0545554
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.0545554
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.0545554
EAST SYNDROME	0.000545554	0.0545554
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.0545554
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.0545554
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.0545554
FETAL HYDANTOIN SYNDROME	0.000545554	0.0545554
FETAL ALCOHOL SYNDROME	0.000545554	0.0545554
TRISOMY 8Q	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000545554	0.0545554
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
DISTAL TRISOMY 18Q	0.000545554	0.0545554
MOSAIC TRISOMY 14	0.000545554	0.0545554
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.0545554
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.0545554
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.0545554
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.0545554
DISTAL MONOSOMY 9P	0.000545554	0.0545554
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.0545554
2P21 MICRODELETION SYNDROME	0.000545554	0.0545554
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.0545554
MONOSOMY 18P	0.000545554	0.0545554
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.0545554
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.0545554
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.0545554
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.0545554
VICI SYNDROME	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.0545554
OPTIC PATHWAY GLIOMA	0.000545554	0.0545554
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.0545554
PENTASOMY X	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.0545554
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.0545554
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000545554	0.0545554
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.0545554
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.0545554
CITRULLINEMIA TYPE II	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000545554	0.0545554
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.0545554
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000545554	0.0545554
RFT1-CDG	0.000545554	0.0545554
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.0545554
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.0545554
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.0545554
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.0545554
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.0545554
CURRARINO SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.0545554
8P11.2 DELETION SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.0545554
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.0545554
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.0545554
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.0545554
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.0545554
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.0545554
MICROVILLUS INCLUSION DISEASE	0.000545554	0.0545554
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.0545554
TRANSALDOLASE DEFICIENCY	0.000545554	0.0545554
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.0545554
USHER SYNDROME TYPE 1	0.000545554	0.0545554
2Q37 MICRODELETION SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.0545554
DUANE RETRACTION SYNDROME	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.0545554
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.0545554
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.0545554
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.0545554
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.0545554
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.0545554
ARGININOSUCCINIC ACIDURIA	0.000545554	0.0545554
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.0545554
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.0545554
LISSENCEPHALY 8; LIS8	0.000545554	0.0545554
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.0545554
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.0545554
FUCOSIDOSIS	0.000545554	0.0545554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.0545554
ISOLATED PLAGIOCEPHALY	0.000545554	0.0545554
EPIDERMAL NEVUS SYNDROME	0.000545554	0.0545554
GALACTOSEMIA	0.000545554	0.0545554
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.0545554
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 21	0.000545554	0.0545554
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000545554	0.0545554
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.0545554
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000545554	0.0545554
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.0545554
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.0545554
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.0545554
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.0545554
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.0545554
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.0545554
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.0545554
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000545554	0.0545554
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.0545554
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.0545554
WILSON-TURNER SYNDROME	0.000545554	0.0545554
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 2	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.0545554
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.0545554
WEBB-DATTANI SYNDROME; WEDAS	0.000545554	0.0545554
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.0545554
FARBER DISEASE	0.000545554	0.0545554
TRICHOTHIODYSTROPHY	0.000545554	0.0545554
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.0545554
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.0545554
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.0545554
TRISOMY X	0.000545554	0.0545554
CULLER-JONES SYNDROME; CJS	0.000545554	0.0545554
TRISOMY 18	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 7	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.0545554
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.0545554
SECKEL SYNDROME 8; SCKL8	0.000545554	0.0545554
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.0545554
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.0545554
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.0545554
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.0545554
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000545554	0.0545554
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.0545554
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.0545554
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.0545554
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.0545554
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.0545554
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.0545554
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.0545554
DYSTONIA-APHONIA SYNDROME	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.0545554
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.0545554
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.0545554
SALT-AND-PEPPER SYNDROME	0.000545554	0.0545554
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.0545554
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.0545554
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.0545554
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.0545554
STT3A-CDG	0.000545554	0.0545554
STT3B-CDG	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.0545554
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.0545554
GRISCELLI SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.0545554
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.0545554
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
HSD10 DISEASE	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.0545554
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
ISOVALERIC ACIDEMIA	0.000545554	0.0545554
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000545554	0.0545554
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.0545554
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000545554	0.0545554
EVEN-PLUS SYNDROME	0.000545554	0.0545554
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.0545554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.0545554
JOUBERT SYNDROME 26	0.000545554	0.0545554
JOUBERT SYNDROME 25	0.000545554	0.0545554
SECKEL SYNDROME 9; SCKL9	0.000545554	0.0545554
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.0545554
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.0545554
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.0545554
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.0545554
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.0545554
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 24	0.000545554	0.0545554
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.0545554
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.0545554
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.0545554
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.0545554
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.0545554
JOUBERT SYNDROME 27	0.000545554	0.0545554
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.0545554
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.0545554
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000545554	0.0545554
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.0545554
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.0545554
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000545554	0.0545554
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.0545554
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.000545554	0.0545554
ALAZAMI-YUAN SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 28	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.0545554
1P21.3 MICRODELETION SYNDROME	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.0545554
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.0545554
CONGENITAL VARICELLA SYNDROME	0.000545554	0.0545554
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.0545554
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.0545554
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.0545554
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.0545554
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.0545554
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 5	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.0545554
CITRULLINEMIA, CLASSIC	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.0545554
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.0545554
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.0545554
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.0545554
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.0545554
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.0545554
SENIOR-LOKEN SYNDROME 9	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.0545554
ABETAL34V AMYLOIDOSIS	0.000545554	0.0545554
SRD5A3-CDG	0.000545554	0.0545554
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.0545554
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.0545554
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.0545554
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.0545554
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.0545554
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000545554	0.0545554
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.0545554
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.0545554
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.0545554
OXOGLUTARIC ACIDURIA	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.0545554
SARCOSINEMIA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.0545554
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.0545554
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.0545554
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.0545554
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.0545554
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.0545554
CHOPS SYNDROME; CHOPS	0.000545554	0.0545554
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.0545554
COACH SYNDROME	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.0545554
SEVERE CANAVAN DISEASE	0.000545554	0.0545554
SENIOR-LOKEN SYNDROME	0.000545554	0.0545554
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.0545554
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.0545554
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.0545554
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.0545554
